The market has a habit of doing this.

It takes a real concern…

And then prices it like a permanent impairment.

One spending increase becomes a broken thesis.

One margin question becomes a sector-wide reset.

One bad reaction after earnings becomes a reason to sell anything that looks even slightly uncomfortable.

That is where mispricing starts.

Not because the market is always wrong.

But because the market is often impatient.

This month, I screened 182 companies.

Only 95 qualified under the valuation and quality framework.

And from those, I ranked the 10 highest-conviction opportunities based on:

Valuation
Business quality
Balance sheet strength
Downside risk
Dividend strength
Expected return
Capital allocation potential

The question this month was simple:

Where is the market punishing the wrong stocks?

Not the cheapest stocks.

Not the biggest losers.

Not the most obvious dips.

But the companies where the fundamentals still look stronger than the sentiment.

Why May’s Screen Is Different

April was about broad valuation resets.

May is about earnings reactions, sector fatigue, and quality businesses trading below their normal valuation ranges.

That difference matters.

Over the past few weeks, the market has not simply rewarded companies for beating numbers.

It has punished anything that raises a harder question:

Can AI spending generate attractive returns?

Are software multiples still too high?

Is healthcare risk now fully priced in?

Are high-quality compounders finally becoming attractive again?

Is the market overreacting to temporary uncertainty?

That is the setup.

The market is not selling everything equally.

It is becoming more selective.

And selective markets create better stock-picking opportunities.

What Stood Out This Month

The biggest opportunities were not necessarily in the obvious places.

They appeared where investors are currently most uncomfortable.

1. Healthcare is still deeply out of favour

One of the highest-ranked areas in the May screen came from healthcare.

That matters.

This is a sector where the market has become much more cautious.

Investors are worried about:

Regulation
Pricing pressure
Competition
Medical cost trends
Political scrutiny
Whether previous valuation premiums were too optimistic

Those concerns are real.

But after the reset, the numbers look very different.

Several high-quality healthcare businesses now trade at valuations that imply a much more pessimistic future than their long-term fundamentals may justify.

That does not mean the risks have disappeared.

It means the price may finally be reflecting them.

And in some cases, possibly over-reflecting them.

2. Quality technology is being reset

Technology still appeared heavily in the screen.

But this month was not about chasing the most obvious AI names.

It was about quality technology businesses where the multiple has compressed sharply.

Some of these companies are still highly profitable.

Some have strong balance sheets.

Some continue to generate attractive free cash flow.

But the market is no longer willing to pay the same premium unless growth is obvious, margins are protected, and AI risk can be clearly explained.

That is exactly where the screen became interesting.

Not because every technology stock is attractive.

But because some quality businesses are being valued as if their long-term earnings power has permanently weakened.

3. Boring compounders are quietly becoming interesting again

Not every opportunity comes from a dramatic crash.

Some come from slow, quiet multiple compression.

These are the businesses that rarely dominate financial headlines.

They are often:

High-margin
Repeatable
Cash-generative
Asset-light
Disciplined with capital
Less exciting than the market’s favourite stories

They may not have the loudest narratives.

But when these companies move from premium valuations to more reasonable ones, long-term expected returns can improve quickly.

That was a clear pattern in this month’s results.

4. The highest upside was not always the highest ranking

This is important.

The ranking is not purely based on upside.

If it were, the list would simply reward the largest fair value gaps.

But that is not how I want to allocate capital.

The spreadsheet ranks companies using a blended allocation score:

40% valuation
35% quality
15% risk
10% income

That means a company needs more than just upside.

It also needs business quality, balance sheet resilience, dividend support, and downside protection.

That is why this month’s top 10 is not just a list of stocks that fell the most.

It is a mix of quality businesses where valuation, fundamentals, and risk/reward now look more interesting.

The Key Question

This month’s spreadsheet is not asking:

“What is down the most?”

It is asking:

“Where has the market confused short-term fear with long-term damage?”

That is a very different question.

A falling share price is not enough.

A lower multiple is not enough.

A stock being down 30%, 40%, or 50% does not automatically make it attractive.

Sometimes the market is right.

Sometimes the business is weaker.

Sometimes the old valuation was simply too high.

That is why the framework filters for quality first.

The best opportunities this month are the companies where:

The business still appears durable
The valuation has compressed
The balance sheet remains manageable
Free cash flow is still attractive
The market narrative has turned negative
And the long-term earnings power may be underappreciated

That is where expected returns can improve.

Inside the May Spreadsheet

The full May spreadsheet includes:

The complete ranked list
Fair value estimates
Expected upside
Bear case considerations
Quality scores
Valuation scores
Risk scores
Income scores
Allocation rankings
Conviction tiers
The full capital allocation framework

The goal is not to tell you to buy everything.

It is to show where the risk/reward looks most attractive after earnings season.

Because in this kind of market, discipline matters.

The market is giving investors more opportunities than it was a few months ago.

But it is also giving them more traps.

The spreadsheet is designed to help separate the two.

Below, I reveal the full ranked list, including the top 10 stocks, fair value estimates, expected upside, quality scores, risk scores, income scores, allocation rankings, and the full May spreadsheet.

Read more

Visa, Mastercard and American Express are often grouped together as “payment stocks.”

But that description undersells what these businesses really are.

And with Visa and Mastercard both reporting earnings this week, this comparison feels especially timely.

Investors are about to get a fresh look at payment volumes, cross-border spending, consumer resilience, margins, and whether these premium valuations are still justified.

But short-term earnings are only part of the story.

The bigger question is far more important:

If I could only buy one of these three payment giants today, which one offers the best mix of quality, future protection, valuation, dividend growth, and long-term market-beating potential?

At their best, these companies are not just exposed to consumer spending.

They sit underneath global commerce itself.

Every time someone taps a card, pays online, books a hotel, buys groceries, travels abroad, pays for software, or spends through a digital wallet, one of these networks can benefit.

That is what makes this group so powerful.

These are not ordinary financial companies. They are some of the most entrenched businesses in global payments, supported by scale, trust, acceptance, brand power, and the long-term shift away from cash.

And that long-term trend is still visible in the numbers.

Payment volumes have continued to climb over time, even through recessions, inflation shocks, rate cycles, and major changes in consumer behaviour.

That is the appeal of this group.

As more spending moves away from cash and into digital payment networks, Visa, Mastercard and American Express all have a structural tailwind behind them.

But here is where investors need to be careful.

One of the biggest mistakes investors can make is treating Visa, Mastercard and American Express as interchangeable businesses.

They are not.

Visa and Mastercard are open-loop payment networks. They sit between banks, merchants and consumers, processing enormous transaction volumes without taking the same direct lending risk as a card issuer.

American Express is different.

Amex operates a closed-loop model, meaning it acts as the network, the issuer, and the relationship owner. That gives American Express more control over the customer relationship, especially with affluent consumers, but it also gives the business more exposure to credit cycles, lending risk, and consumer stress.

That difference matters.

Visa and Mastercard often look more like global toll roads than traditional financial companies. They benefit from scale, network effects, and high incremental margins, without carrying the same balance-sheet risk as a lender.

That is why their profitability profile is so exceptional.

Very few businesses can sustain margins like this over long periods of time.

And that is exactly why Visa and Mastercard usually trade at premium valuations.

The market knows these are exceptional businesses.

American Express is different again.

It does not have the same pure toll-road model as Visa or Mastercard, but it does have a powerful premium brand, a loyal customer base, and a closed-loop network that gives it deeper insight into both cardholders and merchants.

That can be a real advantage.

But it also means the stock needs to be judged differently.

So this comparison is not simply about asking which company is “best.”

A great business can still be a poor investment if too much optimism is already priced in.

And a cheaper stock can still be a value trap if the market is correctly discounting higher risk.

That is why I wanted to compare Visa, Mastercard and American Express through the lens that actually matters for investors today:

• Business quality

• Future protection

• Downside and recession risk

• Dividend growth potential

• Current valuation

• Potential to outperform the S&P 500 over the next decade

Each company has a different strength.

Visa may be the safest and most predictable.

Mastercard may be the strongest long-term compounder.

American Express may look like the obvious bargain.

But once I adjusted for business model, credit exposure, valuation, dividend growth and downside risk, only one stood out as the stock I would be most willing to buy today.

Paid members get the full ranking, valuation breakdown, buy zones, downside risks, and my top pick today.

Read more

A few weeks ago, the market looked like it was pricing in something much worse.

Oil was surging.
Geopolitical risk was spiking.
Investors were de-risking fast.
And for a brief moment, it felt like the market was starting to brace for a much uglier outcome.

Now the mood has flipped.

The S&P 500 has ripped back toward record highs. Oil has cooled off. Bond yields have steadied. And sentiment has recovered quickly enough that fear is already starting to give way to something closer to optimism again.

That is a big shift in a short period of time.

But under the surface, the picture is less clean than the headline indexes make it seem.

The broader market has recovered sharply, but plenty of individual stocks have not. A surprising number are still sitting near 52-week lows, even as the index pushes higher and investors start looking ahead to the next phase of the rally.

That matters now, because the market is entering a new test.

The panic phase was driven by headlines.
The next phase will be driven by earnings.

Over the next few weeks, investors are going to find out which companies were merely caught in the volatility… and which ones are actually facing weaker fundamentals, weaker demand, or a lower earnings power than the market used to assume.

That distinction matters.

Stocks at 52-week lows often look cheap on the surface. But low prices alone do not create value. In many cases, the market is simply correcting for weaker growth, weaker margins, or a business that deserves a lower multiple than it once had.

That is why I did not want to rely on price alone.

Instead, I re-ran the valuation work on a basket of stocks trading near 52-week lows, using a DCF-based framework to see which names still offered a real margin of safety - and which ones only looked cheap because the market had already priced in a weaker future.

Most did not make the cut.

Only two did.

Why most 52-week lows fail the test

A stock trading near a 52-week low can look tempting.

The price is down.
The chart looks ugly.
Sentiment is weak.
And that is often enough to make investors assume they are looking at value.

Sometimes they are.

But very often, they are not.

A stock does not become cheap just because it has fallen. In many cases, the decline is simply the market adjusting to a weaker reality - slower growth, lower margins, weaker guidance, rising competition, or a business that no longer deserves the multiple investors once gave it.

That is where a lot of people get caught.

They see the drawdown.
They anchor to the old high.
And they mistake a lower price for a better opportunity.

But the old high is not what matters.

What matters is what the business is worth today based on the cash it can generate going forward.

That is why I did not want to build this list around price action alone. I wanted to know which of these 52-week low stocks still offered enough upside based on future cash flows - and which ones only looked attractive because the market had already repriced them lower.

So I ran them through a DCF-based process.

Not as a perfect tool, because no valuation model is. But as a way to force discipline.

For each company, the key question was simple: does the current price still leave enough room for a compelling return, even under assumptions that are not overly generous?

That matters even more right now.

Because with earnings season underway, the market is about to become much less forgiving. Stocks that are already weak will need to show real resilience to stop sliding. And if they cannot, being near a 52-week low today may end up meaning very little.

That is why this screen was useful.

It helped separate the names that are merely down… from the names that may actually be undervalued.

The framework I used

There is no perfect way to value a stock.

A DCF is not a magic answer. Change the assumptions, and the output changes with them. But that is also exactly why it is useful. It forces you to be explicit about what has to happen for a stock to be worth buying.

For this screen, I was not trying to find the stocks with the biggest drawdowns or the most dramatic charts. I wanted to find the names where the current price still looked attractive relative to a realistic range of future cash flows.

So the process was built around a few simple questions.

1. Is the business still high quality?

The first filter was not valuation. It was quality.

If a company is near a 52-week low because the business itself is weakening, the lower price may not be an opportunity at all. It may just be the market catching up to a worse reality.

So I wanted businesses that still showed signs of durability - strong market position, healthy margins, resilient demand, and a model that can continue compounding over time.

2. Are the growth assumptions still believable?

This is where a lot of “cheap” stocks fall apart.

A stock can look optically inexpensive if investors are still anchoring to old expectations. But if the future growth path is now lower, the fair value is lower too.

So for each company, the key question was not whether it used to deserve a higher price. It was whether reasonable forward assumptions still supported upside from here.

3. Is the valuation leaving enough room for error?

This is the margin-of-safety test.

Even if the business is solid, that does not automatically make the stock a buy. The current price still has to leave enough room for decent returns without relying on perfect execution.

That is especially important in this kind of market. When sentiment swings quickly and earnings matter more, I do not want a valuation that only works if everything goes right.

4. Is the downside understandable and survivable?

Some stocks are at 52-week lows because the market is overreacting.

Others are there because the risks are real.

So I also wanted to understand what was actually driving the weakness. Was this mainly sentiment? A temporary slowdown? A margin reset? Or something more structural?

If the downside case looked too open-ended, or the business needed too many things to go right to recover, that was usually enough to move on.

5. Would I still want to own it if the recovery takes time?

This matters more than people think.

A stock near a 52-week low does not have to bounce quickly to be a good investment. But if the thesis only works on the assumption of a fast rerating, it is probably not a very strong thesis.

The names that stood out were the ones where I could still make the case even if the market stayed cautious for a while.

What this process was really designed to do

At a high level, this was not a hunt for the most beaten-down stocks.

It was a hunt for the mispriced ones.

That is a very different exercise.

A large drawdown can create opportunity. It can also create noise. And when a stock is sitting near a 52-week low, the easiest mistake is to assume the discount is the opportunity.

Sometimes it is.

But often, the market is simply telling you that the business, the expectations, or the valuation had to reset.

This framework was my way of filtering that out.

Because the goal was not to find stocks that looked cheap compared with where they used to trade.

It was to find stocks that still looked attractive based on what they can realistically earn from here.

Once I put the list through that lens, the field narrowed quickly.

A stock that failed the test: Novo Nordisk

Novo Nordisk looked tempting at first glance.

The stock is near its 52-week low.

Its forward P/E has compressed to about 12x, far below its five-year average of roughly 30x. Its dividend yield has jumped to around 4.6%, which is also well above normal.

That is exactly the kind of setup that can pull investors in.

But when I ran the DCF, the story changed.

My intrinsic value came out at roughly $39.37, versus a market price around $40, leaving a negative margin of safety of about 1.6%. Even the implied upside to the Wall Street target was only around 8%.

So while Novo looked much cheaper than usual, it still did not look cheap enough.

That is the difference between a stock being down a lot and a stock being undervalued.

Novo may recover over time. But for this list, it did not offer enough valuation support to make the final cut.

A stock that came close, but still did not make the cut: Medtronic

Unlike Novo Nordisk, Medtronic did not fail because it still looked outright overvalued on my numbers.

If anything, the stock looked roughly fairly valued to modestly undervalued, with my DCF pointing to value in the high $80s to low $90s against a share price around $86.

But that was also the problem.

For this list, I was not looking for stocks that merely looked reasonable. I was looking for names where the valuation itself created a more obvious opportunity.

And Medtronic did not quite get there.

The forward P/E and dividend yield also sit close to their historical norms, which makes this look less like a market overreaction and more like a stock trading in a range that is broadly understandable. There may be upside from here, and the Wall Street target suggests as much, but the valuation discount was not wide enough for me to put it in the top tier.

So Medtronic was not a clear reject in the same way as Novo Nordisk.

It was more of a near miss.

A stock I could understand owning, but not one that stood out enough to make my final cut when I was specifically looking for the strongest opportunities near 52-week lows.

That was the pattern across much of the list.

Some stocks looked cheaper than usual, but still not cheap enough. Others were solid businesses, but the valuation discount was too thin to make them stand out. And a few simply needed too much to go right.

In the end, only two names offered the combination I was looking for:

• a business I still wanted to own

• assumptions I could reasonably defend

• and a valuation that left enough room for upside from here

Here are the two names that still offered the combination of quality and valuation support I was looking for.

Read more

S&P 500 Performance in April so far

Markets have already bounced.

That usually convinces investors the opportunity is gone.

Often, it is.

Broad selloffs create broad discounts at first. But once the rebound begins, the market stops rewarding everything equally. The easy upside disappears quickly. What remains is narrower, more selective, and often far more interesting.

That is the setup this month.

The S&P 500 has recovered sharply from its recent lows, and sentiment has improved across several parts of the market. But even after that rebound, a small group of large-cap companies still trade at meaningful discounts to consensus value.

This report focuses on those remaining gaps.

Not where prices have already recovered, but where valuation still appears disconnected from business quality, earnings power, and long-term upside.

Large-cap opportunities rarely stay obvious for long.

Once markets stabilize, the broad repricing phase ends. What remains is a narrower group of companies where the valuation reset has not fully reversed despite durable fundamentals, strong cash generation, and analyst expectations that still point materially higher.

Rather than chasing what has already bounced hardest, this report isolates the remaining S&P 500 names where upside still appears asymmetric relative to downside risk.

This Month’s Screening Framework

To identify those opportunities, I screened the S&P 500 for large-cap companies meeting the following criteria:

• Market capitalisation above $10B

• Minimum 20% projected 12-month upside

• Analyst consensus of Moderate Buy or Strong Buy

• Durable underlying business quality

• Balance sheet and cash flow profile strong enough to support real capital allocation

After applying those filters, 500 companies were screened.

From those, 58 qualified.

That matters.

In a broad selloff, many stocks can look optically cheap. After a rebound, far fewer still do. That makes this month’s list more selective and, in many cases, more actionable.

Some names have already seen their valuation gaps close. Others have not. In several cases, the market appears to have moved on faster than the fundamentals have changed.

Those are the opportunities this report aims to isolate.

April at a Glance

• Companies screened: 500

• Final qualifying stocks: 58

• Minimum projected upside: 20%

• Universe: S&P 500, market caps above $10B

• Objective: identify large-cap companies where valuation, quality, and forward upside still diverge meaningfully even after the rebound

From the final qualifying group, a smaller subset stands out most clearly based on:

• valuation support

• business durability

• analyst alignment

• risk-adjusted upside

• downside support from current levels

Five stand out most clearly this month.

They are ranked based on:

• Upside potential

• Business quality

• Valuation compression

• Downside support levels

• How actionable the setup still looks after the recent rebound

The companies below represent the clearest remaining opportunities currently screening in the S&P 500.

This Month’s Top 5 High-Upside S&P 500 Stocks

Several names have already bounced sharply from the lows.

These five still stand out because the upside has not fully closed.

The lower-ranked names are interesting.

The top-ranked names still look actionable.

#5 — Newmont Corporation (NEM)

Newmont stands out this month for a different reason than the other names on this list.

The opportunity here is not being driven by a high-growth technology narrative or a temporary sentiment reset around software or financials.

Instead, it comes from a large-cap, cash-generative business where the market still appears to be underestimating the combination of earnings power, margin strength, and valuation support.

That makes Newmont one of the more interesting remaining setups in the screen.

What the Market Is Pricing In

At current levels, investors still appear cautious on the broader gold and mining complex.

That hesitation is understandable.

Mining businesses are cyclical, operationally intensive, and often treated as lower-quality opportunities than asset-light compounders. They also tend to screen cheaply for a reason when commodity expectations are unstable.

But Newmont’s current setup looks stronger than that broad market perception suggests.

The company remains the clear scale leader in the space, and the underlying financial profile has improved materially.

Valuation Context

Even after the recent rebound, Newmont still trades at a notable discount to its own historical valuation.

Its forward P/E currently sits around 12.2x, versus a 5-year average closer to 15.9x.

That matters.

Because while the stock has recovered from earlier weakness, the market is still valuing the business below its normal earnings multiple despite a much stronger profitability backdrop than investors typically associate with the sector.

That creates a more attractive setup than the headline dividend yield alone might suggest.

Business Quality

This is where the story gets more interesting.

Newmont’s valuation screen on the surface looks mixed, largely because sales-based multiples remain elevated relative to the sector. But the underlying operating picture is much stronger than that first impression suggests.

Growth metrics remain robust, including:

• 21.3% revenue growth

• 56.3% EBITDA growth

• 86.2% EBIT growth

• 123.4% EPS diluted growth

• 46.5% forward EPS growth

• 28.1% long-term EPS growth expectation

Those are not weak numbers.

They point to a business benefiting from a much stronger earnings environment than the market may still be fully crediting.

Profitability is also unusually strong for the sector.

Newmont currently carries an A+ profitability grade, supported by:

• 63.2% gross margin

• 48.6% EBIT margin

• 61.1% EBITDA margin

• 31.3% net income margin

• 41.9% levered free cash flow margin

• 17.5% return on total capital

For a mining company, that is a very strong operating profile.

Why It Ranks #5

Newmont ranks #5 this month because it combines three things that rarely show up together cleanly:

• large-cap scale

• strong profitability

• a forward valuation still below its historical norm

The current dividend yield of roughly 0.9% is well below its 5-year average, which may make the stock look less attractive to income-focused investors at first glance.

But that lower yield is really just the mirror image of a stronger share price and improved earnings outlook.

For this screen, the more important point is that the stock still appears reasonably valued relative to its forward earnings power.

Newmont is not the cleanest business model on this list.

It is more cyclical, more commodity-linked, and less predictable than some of the other names ranked above it.

That is why it sits at #5 rather than higher.

But for investors looking for a large-cap name where the valuation still looks supportive and the profitability profile is stronger than the market may appreciate, Newmont remains one of the more compelling remaining opportunities in the screen.

The next four names offer either a larger valuation gap, stronger downside support, or a better overall combination of business quality and upside from current levels.

Two still screen as clear outliers even after the recent rebound.

Paid members unlock:

• The remaining Top 4 ranked stocks

• Exact buy ranges

• Downside scenarios

• The full screening dataset

• My allocation framework across the list

• Which names are actionable now versus watchlist-only

Read more

Most stocks trading near 52-week lows are not bargains.

They are there for a reason.

Sometimes that reason is slowing growth.
Sometimes it is deteriorating fundamentals.
Sometimes the market is simply correcting a valuation that had drifted too far from reality.

That is what makes this part of the market so dangerous.

But it is also what makes it interesting.

Because every now and then, fear does not just hit weak businesses.

It hits strong ones too.

Market Update

The past few weeks have been a reminder that this market is still being driven as much by fear as by fundamentals.

Last 30 days S&P 500 Heatmap

What started as a geopolitical shock quickly spilled into everything else. Oil surged as tensions in the Middle East escalated and investors rushed to price in the risk of a wider disruption.

That immediately brought inflation back into focus:

…pushed rate-cut expectations around:

….and created another burst of volatility across equities.

Since then, sentiment has improved.

Signs of de-escalation and ceasefire hopes have helped cool some of the panic. Oil has come off its highs, markets have bounced, and investors have started to price out the worst-case scenario. But while the headlines have become less severe, the reset in valuations has already happened.

And that is the part that matters.

When markets go through this kind of repricing, they do not always separate weak businesses from strong ones very well. In the short term, premium multiples get compressed, quality gets sold alongside everything else, and stocks that looked untouchably expensive a few months ago can suddenly start to look much more reasonable.

That does not mean every stock near a 52-week low is worth buying.

Far from it.

In many cases, the market is correctly identifying a weaker business, a fading growth story, or a stock that simply never deserved the valuation it once had.

But every now and then, macro fear creates a different kind of setup.

Not in broken businesses.

In strong ones.

That is the focus of this article.

The question is not which stocks are down.

Plenty of stocks are down.

The real question is:

Which high-quality businesses are now trading near 52-week lows for reasons that matter less over the long term than the market currently believes?

And with earnings season starting to build again, this is exactly the kind of setup worth paying attention to.

What I Looked For

I was not looking for the ugliest charts or the biggest drawdowns.

I was looking for something much more specific:

• High-quality businesses with durable competitive advantages

• Stocks near 52-week lows after a meaningful valuation reset

• Setups where the long-term thesis still looks intact, even if short-term sentiment has clearly weakened

In other words, I was not trying to find broken companies.

I was trying to find strong companies that the market has become much less willing to pay up for.

That distinction matters.

Because a stock can be down for good reason.

And a stock can be near its lows without offering any real margin of safety at all.

The opportunity only starts to become interesting when three things happen at once:

• The business remains strong

• Expectations come down

• The starting valuation improves enough to lift forward returns

That is where selective buying starts to make sense.

And that is also why this is not really a screen for “cheap stocks.”

It is a screen for premium businesses with lower expectations.

Some of the names below are not screaming bargains.

Some are closer to fair value than deep value.

But all five, in my view, have become more interesting because the market is no longer pricing them with the same confidence it was just a few months ago.

Below are the 5 bargain stocks near 52-week lows that stand out most to me right now.

1. S&P Global (SPGI)

What S&P Global Actually Does

S&P Global is one of those businesses that looks simple on the surface, but becomes much more powerful the closer you look.

Most investors know the company for its credit ratings business. That alone is a major franchise. Through S&P Global Ratings, the company plays a central role in global debt markets, helping issuers access capital and giving investors a standardized view of credit risk.

But S&P Global is much more than a ratings agency.

The business also owns leading positions in market data, benchmarks, index licensing, and analytics. That includes well-known assets tied to the S&P 500, commodity and mobility data, and a broader ecosystem of financial intelligence tools used across capital markets.

In other words, this is not a cyclical commodity business or a disposable software tool.

It is a deeply embedded information business with recurring revenues, strong pricing power, high margins, and an increasingly important role in how global markets function.

That is why it has historically commanded a premium valuation.

And also why it becomes interesting when that premium starts to compress.

Why SPGI Has Struggled and Is Sitting Near a 52-Week Low

S&P Global is down 20% year to date, with the stock now trading around $415, much closer to its 52-week low of roughly $382 than its high near $579.

At first glance, that kind of drawdown can look unusual for a business of this quality.

But the explanation is fairly straightforward.

The market has become much less willing to pay peak multiples for high-quality compounders, especially those with premium valuations and some sensitivity to macro conditions. In SPGI’s case, the recent backdrop of higher oil prices, renewed geopolitical stress, hotter inflation data, and shifting rate expectations has added another layer of caution across financials and information businesses tied to capital markets activity.

That matters because while S&P Global is an exceptional business, it is not completely immune to macro slowdowns.

Debt issuance can cool. Transaction activity can slow. Sentiment around financial-market-linked businesses can weaken. And when that happens, even elite franchises can go through a valuation reset.

That looks like exactly what has happened here.

Importantly, this does not look like a broken business.

Analysts still expect EPS of $19.62 in 2026 and $22.07 in 2027, implying a healthy growth path from here. Quarterly results have also remained solid overall, with the company beating expectations in three of the last four quarters, and long-term EPS growth expectations still sit around the mid-teens.

So the issue here is not that the business has fallen apart.

The issue is that the stock has been repriced.

Why Now May Be a Great Time to Buy S&P Global

This is where the setup starts to get more interesting.

Even after years of premium treatment, SPGI now trades at roughly 21x forward earnings, well below its 5-year average of 30x.

That is a very meaningful reset for a business with this kind of margin profile, competitive positioning, and historical compounding record.

The profitability remains excellent.

Gross margins sit above 70%.
EBIT margins are above 42%.
EBITDA margins are close to 50%.
Levered free cash flow margins remain above 31%.

Those are elite numbers.

This is still a business with strong pricing power, high recurring revenue, and a role in the financial system that is extremely difficult to replicate. The ratings franchise alone benefits from enormous trust, scale, and relevance. Layer on top the index business, analytics, and market intelligence capabilities, and you have a company that still looks far more like a long-term compounder than a business facing structural decline.

That is what makes the current valuation more compelling.

The intrinsic value work points to a fair value of roughly $550, implying about a 25% margin of safety from current levels. Wall Street’s target near $544 also suggests roughly 31% upside.

And perhaps most interestingly, the reverse DCF implies the market is only pricing in around 6.3% growth from here.

For a company with a 5-year free cash flow CAGR of 11% and a 10-year CAGR of 16%, that hurdle does not look especially demanding.

Valuation

The forward P/E now sits around 21x, versus a 5-year average of 30x.

The DCF arrives at an intrinsic value of roughly $550, with the following range:

• Low case: $472

• Base case: $550

• High case: $640

At a current price near $415, that implies:

• roughly 25% margin of safety to base value

• around 33% upside in the medium case

• and a setup that now looks materially more attractive than it did when the market was still willing to pay close to 30x earnings for the same business

The reverse DCF is also telling.

At today’s price, the market appears to be pricing in only about 6.3% long-term growth.

For a company with SPGI’s asset quality, moat, and long-term cash flow profile, that looks more conservative than excessive.

My Take

S&P Global is exactly the kind of stock I want to pay attention to when markets get more fearful.

Not because it is a deep-value name.

And not because it suddenly became statistically cheap against low-quality peers.

But because this is a premium business that the market has become much less willing to pay peak multiples for, even though the long-term thesis still looks very much intact.

The business remains highly profitable, deeply entrenched, and difficult to replicate. Growth is not explosive, but it does not need to be. When a company of this quality goes from nearly 30x forward earnings to just over 21x, while still offering solid earnings growth and robust cash generation, the forward setup starts to look much more compelling.

For investors willing to focus on quality first and valuation second, SPGI looks like one of the more interesting 52-week-low setups in the market right now.

Verdict

BUY

S&P Global is a good example of what happens when the market stops paying peak multiples for quality. The business remains strong, but the valuation has reset enough to make the setup much more interesting.

Across the rest of this list, the same pattern shows up in different ways - from elite compounders with more obvious consumer or software exposure, to under-the-radar names where expectations now look materially lower than the underlying business quality.

Paid members get the remaining 4 picks, full valuation breakdowns, and my final ranking.

Read more

Most investors do not lose money by buying bad businesses.

They lose money by overpaying for great ones.

That is especially true with the Magnificent 7.

These are some of the best companies in the world. But great businesses do not automatically make great investments. What matters is what is already priced in.

Two months ago, I ran discounted cash flow models across all seven names to see which ones still offered real margin of safety.

Since then, prices have moved. Expectations have shifted. Sentiment around AI, capital spending, and mega-cap tech has changed again.

So I ran the numbers again.

The question is not which businesses are high quality. We already know they are.

The real question is:

Which of these stocks still justify their valuation today - and which ones still require too much optimism?

In this update, I revisited each of the Magnificent 7 using refreshed assumptions around growth, cash flow, and valuation.

Some still look attractive.

Some look closer to fair value.

And a few still look priced for more perfection than I am willing to pay for.

Before getting into each stock, here is the key point:

This is no longer a market where investors can buy mega-cap tech blindly and assume valuation does not matter.

Multiples have already started to compress in parts of the market. Expectations are getting tighter. And as that happens, the gap between great company and great stock matters more.

That is why I wanted to rerun the models now.

Because when leadership narrows, pricing changes fast.

And when pricing changes fast, expected returns can change with it.

What Changed?

Compared with my last review, three things matter most:

1. Prices moved.
Even when the business stays the same, a different starting price changes the return profile.

2. Expectations shifted.
Some of these names are no longer being priced like unstoppable straight-line winners. That creates opportunity in a few cases - but not all.

3. Valuation dispersion is widening.
The Magnificent 7 are often discussed as one group, but the market is not valuing them that way anymore. Some now look far more attractive than others.

That makes this a much better environment for selective buying - and a worse one for lazy buying.

Microsoft (MSFT)

Valuation

Microsoft now trades at roughly 21x forward earnings, well below its 5-year average of 31x.

That is a meaningful reset for one of the market’s highest-quality businesses and immediately puts the stock back into serious consideration from a valuation perspective.

The setup is simple: this is not a broken business trading cheaply for a reason. It is a premium business that has become materially less expensive.

DCF Snapshot

• Reverse DCF / implied growth: 8.3%

• 5Y FCF CAGR: 8%

• 10Y FCF CAGR: 13%

• Low case intrinsic value: $440

• Base case intrinsic value: $481

• High case intrinsic value: $526

  

• Current price: ~$373

• Margin of safety: ~22.5%

What Changed

Since my last review, the main change is straightforward: the stock price fell and the multiple compressed.

That matters because expected returns improve when the entry price drops, even if the business itself remains largely intact. In Microsoft’s case, the reset in valuation has made the stock more interesting without requiring a dramatic change in the underlying thesis.

What the Market Is Pricing In

At today’s price, the market appears to be assuming a much more moderate growth path than Microsoft has historically delivered. The reverse DCF suggests the stock only needs to compound free cash flow at roughly 8.3% to justify the current valuation.

For a business with Microsoft’s scale, recurring enterprise relationships, cloud exposure, and AI optionality, that hurdle does not look especially demanding.

In other words, the market is no longer pricing Microsoft like an untouchable compounder. It is pricing it much closer to a mature platform - and that is where the opportunity starts to improve.

My Take

Microsoft remains one of the highest-quality businesses in public markets, and the valuation is finally starting to reflect more caution than confidence.

That does not mean the stock is risk-free. Expectations around Azure, AI monetisation, and enterprise demand still need to be met. But when a business of this quality trades materially below its historical multiple, while still offering a base-case value comfortably above the current price, the risk/reward becomes far more attractive.

Verdict

BUY

Microsoft is currently my #3-ranked stock in the Magnificent 7.

Microsoft is one of the few names where the recent reset has clearly improved the setup. But across the rest of the Magnificent 7, the picture is far less uniform. Some still offer real upside. Others still look priced for more optimism than I’m willing to pay for.

Below, I break down the remaining six names - including which are still buys, which now look closer to fair value, and which still do not offer enough valuation support at today’s prices.

Paid members unlock the remaining 6 stocks, full fair values, and my complete ranking.

Read more

The market doesn’t misprice everything.

But when it does…

It rarely does it subtly.

It compresses multiples across entire sectors.
It sells quality alongside risk.
It prices uncertainty… as if it’s permanent.

And that’s where opportunity lives.

This month, I screened over 80 stocks.

Only 41 met the quality threshold.

And from those…

I’ve ranked the 10 highest-conviction opportunities based on expected return, balance sheet strength, and capital efficiency.

One still shows ~60% upside — even after the recent market bounce.

What’s Happening Right Now

Over the past few weeks, we’ve seen:

• Big Tech rerate from ~24x → ~19–20x forward earnings

• High-quality software names cut in half (in some cases)

• Healthcare trading below historical valuation bands

• Financials drifting despite stable fundamentals

Not because fundamentals collapsed.

But because:

The market is repricing risk - indiscriminately.

And when that happens:

Expected returns improve.

Where the Market Looks Most Wrong Right Now

March was about identifying undervalued compounders.

April goes one step further.

This month answers:

“Where is the market most wrong right now?”

Not just cheap stocks.

But:

• High-quality businesses

• With durable earnings power

• Trading below intrinsic value

• Where multiple compression ≠ fundamental deterioration

How April’s Spreadsheet Is Built

This month’s ranking framework prioritises:

1️⃣ Mispricing Severity

• % gap to 12-month fair value

• Relative to historical valuation ranges

2️⃣ Quality of the Business

• ROIC

• Free cash flow durability

• Margin structure

• Balance sheet strength

3️⃣ Expected Return Profile

• 12-month expected return

• Bear case return

• Downside asymmetry

4️⃣ Allocation Ranking

A combined score of:

• Upside

• Quality

• Balance sheet

• Risk-adjusted return

What Stands Out This Month

1️⃣ Big Tech Is No Longer “Expensive”

Names like:

• Microsoft

• Meta

• Amazon

are now trading closer to market multiples than premium ones.

These are businesses with:

• Structural revenue growth

• Massive free cash flow

• Dominant competitive positioning

Yet multiples have compressed as if growth is fading.

The setup today is very different to 2021.

You’re no longer paying peak multiples for peak narratives.

2️⃣ Software Has Been Reset

Some of the highest-quality software businesses are now trading at levels not seen in years:

• Intuit

• Adobe

• Salesforce

• ServiceNow

In many cases:

• Revenue growth remains intact

• Margins are stable or improving

• Cash flow is strong

But valuations have reset dramatically.

This is multiple compression - not business deterioration.

3️⃣ Healthcare Remains Mispriced

Healthcare continues to offer some of the most asymmetric setups:

• Novo Nordisk

• UnitedHealth

• Zoetis

• Abbott

These businesses benefit from:

• Non-cyclical demand

• Strong pricing power

• Long-term structural growth

Yet many are trading below historical valuation norms.

4️⃣ “Boring” Compounders Are Attractive

Names the market ignores:

• S&P Global

• ADP

• MSCI

• Accenture

These are:

• High-margin

• Asset-light

• Recurring revenue businesses

They rarely look exciting.

But they consistently compound.

And when they dip below fair value…

That’s where long-term returns are built.

How To Use This Spreadsheet

This is not a “buy everything” list.

If I were deploying fresh capital today…

this is where I’d start.

It’s a capital allocation tool.

You can approach it in three ways:

→ Highest Upside

Focus on:

• % from fair value

• Expected return

→ Highest Quality

Focus on:

• ROIC

• Balance sheet strength

• Margin profile

→ Balanced Allocation

Use:

• Allocation ranking

• Conviction tiers

Risk Context

Not every name here is immune to volatility.

Some will:

• Fall further in a recession

• Trade sideways for months

• Look “wrong” before they look right

That’s why the framework includes:

• Bear case returns

• Balance sheet filters

• Quality scoring

Risk doesn’t disappear when valuations compress.
But expected returns improve.

Why This Matters Now

Markets don’t reward patience immediately.

They test it first.

The best opportunities:

• Don’t feel obvious

• Don’t come with certainty

• Don’t look comfortable

They come when:

• Quality is sold

• Narratives turn negative

• And valuations quietly reset

What Paid Members Get

Premium members receive:

• Two fully updated spreadsheets per month

• Ranked capital allocation tables

• 12-month expected return modelling

• Conviction tiers

• Ongoing valuation updates

For £200/year, this is built for investors who want to operate with a clear framework - not guesswork.

This is designed for investors who want:

• Structure

• Discipline

• Repeatable decision-making

Not noise.

If you’re serious about improving your decision-making, this is where to start.

April Spreadsheet Below

Read more

Markets reward growth.

But they reward quality of growth even more.

And most investors don’t know the difference.

They focus on:

• revenue growth

• EPS beats

• headline numbers

All useful.

None sufficient.

Because none of them answer the question that actually matters:

Is this business structurally strong - or just temporarily growing?

That answer doesn’t sit in the headline numbers.

It sits in the income statement - and more importantly, how you read it.

Why Growth Alone Misleads

In strong markets, growth covers everything.

• weak margins get ignored

• inefficient businesses get rewarded

• capital discipline disappears

Because:

Growth creates the illusion of strength.

But margins reveal the truth.

And when conditions tighten, reality shows up fast.

Not gradually.

All at once.

Two companies can grow at the same rate:

same revenue
same narrative
same investor excitement

But produce completely different outcomes.

The difference is simple:

One converts growth into profit.
The other converts growth into cost.

The 10-Second Income Statement Test

If I only had a few seconds to assess a business, I’d look at one thing first:

Operating Margin Trend

Not the level.

The direction.

This is what strength looks like: margins expanding over time, not just revenue growing.

Simple framework:

• Expanding margins → strength

• Flat margins → stability (but limited upside)

• Declining margins → early warning sign

  ---

Why this matters:

Margins tell you what happens after growth.

Anyone can grow revenue.
Very few businesses can grow profitably - and sustain it.

Revenue Quality (Not All Growth Is Equal)

One of the biggest mistakes investors make:

Treating all revenue growth as the same.

It isn’t.

Ask three questions:

1. Is it organic?

• Or driven by acquisitions?

Growth through acquisition often looks strong…

…but comes with:

• integration risk

• higher costs

• lower visibility

  ---

2. Is it pricing or volume?

• Pricing power → strength

• Volume-driven growth → often cyclical

  

  This is pricing-led growth - strong in the short term, but harder to sustain than volume-driven expansion.

  ---

3. Is it durable?

• subscription / recurring → high quality

• one-off / project-based → less predictable

Adobe’s shift to subscription revenue created predictable, recurring growth - this is what durability looks like.

👉 Key idea:

Good businesses grow. Great businesses grow predictably.

Margins: Where the Truth Lives

Revenue tells you what a company sells.

Margins tell you how good the business actually is.

Break it down simply:

Gross Margin → Product Strength

• High = pricing power

• Low = commoditised / competitive

  

  High and rising gross margins like this typically signal pricing power - not commoditisation.

  ---

Operating Margin → Business Model

• Efficiency

• scalability

• cost discipline

  ---

Net Margin → Financial Structure

• interest costs

• tax

• capital decisions

  ---

But if you had to pick one?

👉 Operating margin tells you the most.

Because it reflects:

How well the business converts revenue into real operating profit.

When Growth Becomes a Problem

Here’s where most investors get caught:

Revenue is growing… but margins are falling.

This is the trap: growth looks strong - but the business is getting weaker.

This usually means:

• rising costs

• competitive pressure

• over-expansion

• weakening pricing power

  ---

And this is the key shift:

Growth stops being a tailwind…
and starts masking deterioration.

That’s when you see:

• earnings misses

• multiple compression

• sudden repricing

  ---

Not because the business collapsed.

But because:

The quality of growth was never there.

Earnings Quality (This Is Where It Gets Missed)

Even margins don’t tell the full story.

Because:

Earnings ≠ cash flow

A company can look profitable…

…but still not generate real cash.

Look for:

• stock-based compensation

• “adjusted” earnings

• one-off add-backs

• capitalised costs

  ---

👉 Key idea:

If earnings require explanation, they’re usually weaker than they look.

Connecting This to the Balance Sheet

This is where most investors stop.

And where mistakes happen.

The income statement tells you:

Is this business strong?

The balance sheet tells you:

Can it survive if it isn’t?

If you haven’t read it yet, this is the framework I use to assess risk in under 60 seconds:

You need both.

Because:

• strong margins with weak balance sheets → fragile

• strong balance sheets with weak margins → stagnant

But when both align:

You get durability and upside.

Bringing It Together

A strong business isn’t defined by growth.

It’s defined by alignment:

• high-quality revenue

• expanding (or stable) margins

• clean earnings

• resilient balance sheet

  ---

When all four are present:

The business compounds.

When they aren’t:

Growth becomes noise.

The Real Risk Isn’t Slow Growth

It’s misleading growth.

Because that’s what causes:

• overvaluation

• misplaced confidence

• permanent capital loss

  ---

A Better Way to Think About It

Most investors ask:

“How fast is this company growing?”

A better question is:

“How much of that growth actually turns into profit?”

Because that’s what drives:

• valuation

• durability

• long-term returns

  ---

How I Apply This in Practice

This is exactly why, in my monthly screens:

I don’t just look for:

• revenue growth

• or cheap valuations

Every company must show:

• strong or improving margins

• durable earnings

• and a resilient balance sheet

  ---

Because:

Upside without quality isn’t opportunity.
It’s risk.

What This Looks Like Right Now

In my latest screen:

• 119 companies analysed

• 30 passed initial filters

• a smaller group met my execution threshold

From those:

👉 Five stand out most clearly.

Not just because of upside -
but because downside is controlled.

👉 If you’re allocating real capital,
entry price matters.
downside matters.
and quality determines outcomes.

Unlock the Full Breakdown

🔒 Paid members get access to:

• Top 5 ranked stocks

• Exact buy ranges

• Downside modelling

• Full 30-stock dataset

• Allocation framework

  ---

  👉 Unlock the full report here

  ---

Final Thought

Growth gets attention.

Margins determine outcomes.

And over time:

The market rewards businesses that convert growth into profit - consistently.

Markets reward discipline.
Not growth. Not narratives. Not hype.

👉 If you found this valuable, consider subscribing to get the full monthly reports and future frameworks.

Subscribe to Dividend Talks

Get:

• Monthly valuation screens

• High-upside stock ideas

• Deep-dive frameworks like this

Most dividend investors don’t underperform because they pick bad companies.

They underperform because they pick:

• stable businesses

• with decent yields

• at the wrong price…

• with the wrong balance sheet…

• and limited upside.

Over time, that combination quietly lags the S&P 500.

Over the last 20 years:

- The S&P 500 returned ~7.5% annually
- The average investor achieved just ~2.9%

That gap isn’t about access.

It’s about decision-making.

So the goal isn’t just to find “good dividend stocks”.

The goal is to find:

dividend stocks that compound capital AND income - while being mispriced today

That’s a very different filter.

In this article, I’ll walk through the full framework I use - the same one behind my recent screen:

Here’s the exact framework I use to find dividend stocks that can actually outperform the S&P 500 - not just provide income.

Over the last 12 months, applying this framework has consistently led me toward:

- Companies trading below historical valuation ranges
- Businesses with stronger balance sheets than peers
- Stocks with clear upside vs current expectations

In fact, in my latest screen:

119 stocks → 30 qualified → just 5 stood out.

That’s less than 5% of the market.

That’s the level of selectivity required to outperform.

Step 1: Start With Total Return - Not Yield

This is where most investors go wrong.

They optimise for:

• Yield

• Dividend history

• Stability

But the market doesn’t reward yield.

It rewards:

earnings growth + multiple expansion

Dividend is just a component of total return.

So the first question I always ask is:

👉 “Can this business outperform the S&P 500 from here?”

If the answer is unclear - I move on.

Step 2: Growth Drives Everything (Even for Dividend Stocks)

A dividend stock without growth becomes a bond proxy.

That means:

• Limited upside

• High sensitivity to rates

• Underperformance in strong markets

So I focus on:

What actually matters:

• 5–10Y revenue CAGR

• EPS growth consistency

• Margin expansion (or stability)

What I avoid:

• Flat revenue + “financial engineering” EPS

• Cyclical spikes mistaken for growth

Because over time:

growth is what drives both dividend increases AND valuation rerating

Step 3: Free Cash Flow Is the Truth

Earnings can be managed.

Cash flow is harder to fake.

Free cash flow tells you what a business actually generates after reinvestment.

It strips away accounting noise and shows:

- what’s real
- what’s sustainable
- and what can actually fund dividends

At a basic level:

This is why I always prioritise:

- consistent FCF generation
- strong FCF conversion (earnings → cash)
- and coverage of the dividend

Because when cash flow weakens, the dividend is usually next.

This is one of the biggest edges most investors ignore.

I look for:

• Consistent free cash flow generation

• FCF growing faster than dividends

• Low conversion risk (i.e. earnings ≈ cash)

Why this matters:

A company can:

• look cheap on P/E

• show a “safe” payout ratio

…but still be at risk if cash flow doesn’t support it.

This is exactly how dividend cuts catch people off guard.

Step 4: The Balance Sheet (This Is Where Most Investors Fail)

This is the part most investors underestimate - until it’s too late.

Two companies can look identical on valuation…

But have completely different risk profiles based on:

• Debt levels

• Refinancing timelines

• Interest coverage

• Liquidity

This is why I always stress:

The balance sheet matters more than valuation

I broke this down in detail here:

If you ignore this step, you’re not investing - you’re guessing.

Step 5: Dividend Safety ≠ Dividend Yield

High yield is often a warning sign, not an opportunity.

Instead, I focus on:

• FCF payout ratio (not earnings)

• Stability of the underlying business

• Capital allocation discipline

Because:

a growing 2–4% yield will outperform a declining 7% yield over time

This is what most investors underestimate.

It’s not the starting yield that matters -
it’s what that yield becomes over time.

The difference comes from:

- underlying business growth
- cash flow expansion
- and the ability to consistently increase the dividend

This is why I prioritise dividend safety and growth over headline yield.

Step 6: Valuation - The Actual Driver of Outperformance

This is where everything comes together.

Even the best companies underperform if you overpay.

So I compare:

• Forward P/E vs 5-year average

• FCF multiple vs historical range

• Current sentiment vs fundamentals

What I’m really looking for is:

valuation compression in high-quality businesses

This is what valuation compression looks like in practice.

A high-quality business…
trading well below its historical multiple.

Nothing about the business has fundamentally broken.

But sentiment has changed - and the multiple has compressed.

That’s where the opportunity comes from.

Because if the business continues to perform…
the valuation doesn’t need to expand much for strong returns.

That’s where asymmetry exists:

• downside protected by quality

• upside driven by rerating

Step 7: Expectations vs Reality (The Final Filter)

Stocks don’t move based on what is happening.

They move based on:

what changes vs expectations

So I always ask:

• What does the market expect today?

• What would need to go right for upside?

• What is already priced in?

This is where the edge comes from.

Putting It All Together

When a stock meets all of these criteria, you get:

• Growth

• Cash flow strength

• Balance sheet resilience

• Dividend safety

• Attractive valuation

• Mispriced expectations

That’s the combination that can:

outperform the S&P 500 - not just match it

So the real question is:

👉 Which dividend stocks actually pass all 7 filters today?

Because most don’t.

When I applied this framework across 119 stocks:

- Only 30 made it through
- Just 5 ranked highest for risk-adjusted upside

These aren’t just “good dividend stocks” -
they’re the ones where valuation, balance sheet, and expectations all align.

Instead of repeating the picks here, I’ve already broken that down in full detail.

Most investors won’t look this deep.

That’s where the edge comes from.

If you want to find dividend stocks that can actually outperform the market - not just generate income - that’s exactly what I focus on inside the paid newsletter.

Each month, I break down:

- The few stocks that actually pass this framework
- Where the market is mispricing risk vs upside
- Which opportunities I have the highest conviction in

You don’t need more stock ideas.

You need a better way to filter them.

That’s what this gives you.

Most investors don’t underperform because they lack access.

They underperform because they lack a framework.

This is mine.

What you get as a paid subscriber:

• Monthly stock screens (like this one)

• Full valuation models (DCF + comps)

• Buy / Hold / Avoid ratings

• Positioning + conviction levels

  ---

If this helped you, share it:

If you found this framework useful, feel free to share it with others:

👉 Share this post
👉 Forward to a friend

It helps more than you think.

Markets reward discipline.

But most investors spend their time in the wrong place.

They focus on:

• valuation multiples

• growth rates

• analyst price targets

All useful.

None sufficient.

Because none of them answer the one question that ultimately matters:

Can this business withstand pressure?

That answer doesn’t sit in the income statement.

It sits on the balance sheet.

And most investors only realise that when it’s too late.

By then, the damage is already done.

Why This Only Shows Up When It’s Too Late

In strong markets, balance sheets are largely ignored.

• credit is cheap

• liquidity is abundant

• refinancing is easy

Weakness doesn’t disappear.

It just gets delayed.

But when conditions tighten, the difference between companies becomes obvious very quickly.

Not gradually.

All at once.

Two businesses can look identical on the surface:

• similar growth

• similar margins

• similar valuation

But produce completely different outcomes.

The difference is rarely the business model.

It’s this:

One has flexibility. The other has constraints.

---

The 10-Second Balance Sheet Test

If I only had a few seconds to assess a company’s financial strength, I would start with one metric:

Net Debt relative to earnings power

In simple terms:

After accounting for cash, how many years of earnings would it take to repay the debt?

This is typically measured as:

Net Debt / EBITDA

How to Use It

Start with:

Total Debt – Cash = Net Debt

Then compare it to earnings.

As a rough framework:

• < 1x → structurally strong

• 1–3x → manageable

• 3–5x → increasingly dependent on stable execution

• 5x+ → vulnerable to disruption

  ---

What This Looks Like in Practice

At the lower end of the spectrum (<1x Net Debt / EBITDA), you’ll typically find businesses with:

• strong free cash flow generation

• high margins

• and minimal reliance on external financing

Examples often include:

• large-cap technology companies with net cash positions

• asset-light software platforms

• and certain high-quality compounders

These businesses don’t just survive downturns.

They operate from a position of strength.

They don’t need capital markets.

That’s the key difference.

But This Is Only the Starting Point

One of the biggest mistakes investors make is reducing balance sheet analysis to a single ratio.

Net Debt / EBITDA is useful.

But it doesn’t tell the full story.

A proper assessment looks at three things:

1. Liquidity (Short-Term Survival)

Before anything else, ask:

Can this business meet its obligations over the next 12–24 months?

Simple framework: liquidity determines whether a company can survive short-term stress.

This is where most problems start.

Look at:

• cash

• short-term assets

• vs short-term liabilities

A company can be “cheap” and still run into trouble if liquidity is weak.

Because:

• refinancing may be required

• capital may need to be raised

• or assets may need to be sold

  ---

Simple signal:

• Strong liquidity → flexibility

• Weak liquidity → dependence

And dependence is risk.

2. Debt Structure (When does the risk actually show up?)

Not all debt is equal.

What matters is:

When it needs to be repaid.

Two companies with identical leverage can have very different risk profiles.

One might have:

• long-dated debt

• fixed rates

• minimal near-term refinancing

The other might have:

• near-term maturities

• floating-rate exposure

• refinancing risk

  ---

💡 Key insight:

Most investors don’t get into trouble because a company has debt.

They get into trouble because that debt becomes relevant at the wrong time.

---

3. Cash Flow vs Earnings (Can the company actually handle it?)

EBITDA is useful.

But it isn’t cash.

What matters is:

How much real cash the business generates after everything else.

Look at:

• free cash flow

• capital intensity

• consistency of cash generation

Because:

A company can look profitable on paper…

…but still struggle to manage its obligations in reality.

Bringing It Together

A strong balance sheet isn’t defined by one number.

It’s defined by alignment.

A strong balance sheet creates flexibility.
A weak one creates constraints.

It’s defined by alignment:

• manageable leverage

• strong liquidity

• predictable cash flow

• sensible debt structure

When all four are present:

The business has flexibility

When they aren’t:

The business becomes fragile

---

The Real Risk Isn’t Debt — It’s Fragility

Debt doesn’t kill businesses.

Fragility does.

Leverage simply exposes it.

When flexibility disappears:

• small problems become big problems

• refinancing becomes expensive

• optionality disappears

That’s when you see:

• dilution

• dividend cuts

• forced decisions

• permanent repricing

  ---

A Better Way to Think About Risk

Most investors ask:

“Is this stock cheap?”

A better question — and the one that actually matters — is:

“What happens if things go slightly wrong?”

Because if the balance sheet is strong:

• time is on your side

• the company can adapt

• valuation tends to recover

If it isn’t:

• time works against you

• and downside compounds

  ---

Why This Matters Right Now

Over the past few weeks, markets have repriced risk quickly.

Across multiple sectors, large-cap companies have seen meaningful pullbacks.

That creates opportunity.

But also risk.

Because:

Not all drawdowns are mispricings.

Some are opportunities.

Others are early warnings.

The balance sheet is often what separates the two.

How I Apply This in Practice

This is exactly why, in my monthly screens, I don’t just look for upside.

Every company in my screen passes this balance sheet framework before valuation is even considered.

I filter for companies where:

• valuation is attractive

• earnings are durable

• and the balance sheet provides flexibility

Because:

Upside without durability isn’t opportunity. It’s leverage disguised as value.

---

What This Looks Like in the Current Market

In my latest report:

• 119 companies were screened

• 30 qualified based on strict criteria

• A smaller group met my execution threshold

From those, five stand out most clearly.

Not just because of upside.

But because:

• downside is defined

• balance sheets are resilient

• and risk/reward is asymmetric

  ---

Unlock the Full Breakdown

🔒 Paid members get access to:

• The Top 5 ranked stocks this month

• Exact buy ranges

• Downside modelling

• The full 30-stock screening dataset

• Allocation framework

If you’re allocating real capital:

Entry price and downside matter just as much as upside.

---

Final Thought

Most investors focus on what can go right.

The balance sheet tells you what can go wrong.

And over time:

Avoiding permanent losses matters more than capturing every opportunity.

Markets reward discipline.
Not optimism. Not narratives. Not hope.

👉 If you found this valuable, consider sharing or upgrading to access the full monthly reports.

Markets have repriced risk quickly over the past few weeks.

Across technology, financials, and consumer sectors, several large-cap companies have seen double-digit pullbacks, pushing valuations back toward levels not seen in years.

For long-term investors, that type of reset matters.

Not because falling prices are inherently attractive - but because valuation compression often creates opportunity when underlying business fundamentals remain intact.

Large-cap companies rarely offer both durable earnings power and meaningful upside at the same time.

This month, several do.

Rather than focusing on macro headlines, this report focuses on something more actionable:

Where valuation and fundamentals have temporarily diverged.

When expectations reset faster than earnings power, risk/reward can shift materially in favor of disciplined investors.

🔎 This Month’s Screening Framework

To identify those situations, I screened the market for large-cap companies showing meaningful upside potential.

Each company had to meet the following criteria:

• Market capitalization above $10B
• Minimum 20% projected 12-month upside
• Analyst consensus of Moderate Buy or Strong Buy
• Durable underlying fundamentals and cash flow

After applying those filters, 119 companies were screened.

From those, 30 companies qualified.

That number alone highlights something important:

Meaningful upside opportunities rarely appear broadly across large-cap markets at the same time.

What stands out this month is how many companies are now trading near multi-year valuation compression despite relatively stable earnings expectations.

Market selloffs tend to be broad.

But mispricing is rarely evenly distributed.

Some companies fall because fundamentals weaken.

Others fall simply because investor sentiment resets faster than the business itself.

Those are the opportunities this report aims to identify.

📊 March at a Glance

Companies screened: 119

Final qualifying stocks: 30

Minimum projected upside: 20%

Focus: Large-cap companies ($10B+)

Objective:

Identify asymmetric setups where valuation compression meets durable fundamentals.

From the 30 qualifying names, a smaller group meets my personal execution threshold based on:

• valuation support
• business durability
• analyst alignment
• risk-adjusted upside

Five stand out most clearly.

They are ranked based on:

• Upside potential
• Business quality
• Valuation compression
• Downside support levels

The companies below represent the clearest opportunities currently screening in the market.

🏆 This Month’s Top 5 High-Upside Stocks

#5 — Microsoft (MSFT)

Microsoft rarely screens as a high-upside opportunity.

This month, it does.

Shares have pulled back alongside broader technology stocks as investors reassess the scale of AI infrastructure spending across the industry.

That reset has pushed the forward valuation closer to the lower end of its historical range - despite Microsoft continuing to generate exceptional free cash flow.

What the Market Is Pricing In

At current levels, investors appear to be pricing:

• Slower Azure growth normalization
• Elevated AI capital expenditures
• Margin stabilization rather than expansion

Those concerns are reasonable in the short term.

But they do not suggest structural impairment.

Microsoft remains one of the most dominant enterprise platforms in the world, with durable revenue streams across:

• cloud infrastructure
• enterprise software
• productivity ecosystems

Valuation Context

The forward P/E now sits near the lower end of its historical range.

Under normalized growth assumptions, that creates a much more attractive entry point than investors have seen in recent years.

Microsoft ranks #5 this month.

Most selections from February’s report have already outperformed the S&P 500 despite broader market weakness - highlighting how quickly sentiment can reverse when valuations reset.

The next four names show materially larger valuation gaps.

Two are trading near multi-year lows relative to earnings power.

🔒 Paid members unlock:

• The remaining Top 4 ranked stocks
• Exact buy ranges
• Downside modeling
• The full 30-stock screening dataset
• Portfolio allocation framework

If you’re deploying real capital, entry levels matter as much as upside projections.

Read more

Markets faced something of a perfect storm this week.

Oil prices surged following escalating tensions in Iran, raising concerns about a renewed inflation shock. At the same time, a weaker-than-expected payroll report added to fears that economic growth may be starting to slow.

The combination triggered a broad risk-off move across global markets.

Equities pulled back, bond yields jumped, and investors rapidly reduced risk exposure as they attempted to assess the implications for both inflation and monetary policy.

Despite this volatility, the S&P 500 remains only a few percent below all-time highs and is still up roughly 17% over the past year.

In other words, sentiment has deteriorated quickly, but the broader market structure remains relatively resilient.

Periods like this are important for investors.

When fear rises and volatility spikes, markets often begin to create temporary valuation dislocations.

And that’s exactly what my valuation framework attempts to identify.

When volatility rises, my focus is simple: find high-quality businesses trading below intrinsic value.

Market Sentiment Has Shifted Rapidly

Investor sentiment deteriorated sharply during the past week.

The Fear & Greed Index dropped to 27, firmly within “Fear” territory.

When sentiment indicators move into fear territory, it often signals that investors are becoming excessively cautious in the short term.

Historically, these environments have often created attractive entry points for long-term investors, particularly when strong companies are sold alongside weaker businesses during broad market pullbacks.

What Happened In Markets Last Week

The S&P 500 heatmap highlights the uneven nature of the recent selloff.

Large technology companies such as Microsoft and Broadcom held up relatively well, while weakness across healthcare, consumer staples and financials weighed on the broader market.

Several mega-cap companies - including Apple and Alphabet - also declined as investors rotated capital amid rising macro uncertainty.

This type of dispersion is important.

It suggests that investors are not indiscriminately selling everything, but instead are reallocating capital as they reassess risks tied to inflation, interest rates and geopolitical tensions.

Weak Payroll Data Added To Market Concerns

The latest payroll report surprised markets to the downside.

February payrolls declined by 92,000 jobs, significantly below expectations for a modest gain.

Revisions to previous months also revealed weaker hiring momentum than initially reported.

While one month of data should not be overinterpreted, the report raised concerns that the labour market may be cooling more quickly than previously expected.

However, the unemployment rate remains relatively low at 4.4%, suggesting the labour market is slowing but not collapsing.

Oil Prices Are Creating A New Inflation Risk

At the same time, energy markets delivered a major shock.

Oil prices surged more than 30% following the escalation of tensions in Iran.

Historically, large energy price shocks have sometimes coincided with economic downturns.

However, the relationship between oil prices and the U.S. economy has changed significantly over the past several decades.

The United States now produces far more energy domestically and is far less dependent on imported oil than it was during the energy crises of the 1970s.

As a result, the economy today is far more resilient to energy price shocks.

Inflation Could Temporarily Rise Again

Even so, higher oil prices are likely to feed into inflation data in the coming months.

Energy accounts for roughly 6% of the CPI basket, meaning increases in oil prices can push headline inflation higher even if underlying economic conditions remain stable.

Based on current futures pricing, the energy shock could push inflation modestly higher during 2026 before gradually fading.

This dynamic creates a dilemma for policymakers.

Normally, weak labour data would increase expectations for interest rate cuts.

However, rising energy prices may force the Federal Reserve to delay easing policy, which is one reason markets reacted negatively this week.

Upcoming Earnings This Week

Investors will also be closely watching several earnings reports in the coming days.

Companies such as Oracle and Adobe could provide additional insight into enterprise software demand and broader technology spending trends.

While this week’s earnings calendar does not include many mega-cap names, the results may still provide signals about corporate spending trends across the economy.

Why This Matters For Investors

Periods of macro uncertainty often create short-term pricing inefficiencies.

When investors reduce risk broadly, even strong businesses can sell off alongside weaker companies.

This is where disciplined valuation frameworks become valuable.

Each week I screen the market for companies that meet several key criteria:

• Durable competitive advantages
• Strong free cash flow generation
• Long-term growth drivers
• Attractive valuations relative to historical ranges

This week, three companies triggered buy signals in my valuation model.

At the same time, two widely owned stocks currently appear less attractive based on their growth outlook and valuation.

Subscribe now

I publish research like this every week - breaking down markets and identifying stocks trading below intrinsic value.

Subscribe to access the full analysis.

Read more

U.S. equity futures are down 2–5% pre-market as geopolitical tensions escalate between the U.S. and Iran.

Oil is rising.
Volatility is spiking.
Risk appetite is shrinking.

And when markets react fast, prices often reset faster than fundamentals.

That’s where opportunity begins.

Rotation Is Already Underway

Markets are not falling evenly.

International equities have outperformed.
Value has outperformed growth.
Small caps have diverged from mega caps.

This is dispersion.

Dispersion creates mispricing.

And mispricing creates edge - if you know how to measure it.

Even the AI Trade Is Splitting

Semiconductors have surged.

Software has lagged.

Same theme. Same macro narrative.

Very different price action.

That’s not collapse.

That’s capital rotating.

When leadership narrows, valuation gaps widen.

And when valuation gaps widen, forward return dispersion increases.

Earnings Are Not Collapsing

S&P 500 earnings are up 14%.

That’s the fifth straight quarter of double-digit growth.

This matters.

Because if earnings continue growing while multiples compress, expected returns rise mechanically.

The business doesn’t need to improve.

The price just needs to overshoot.

Long-Term Trend vs Short-Term Fear

Technology continues increasing productivity without destroying economic output.

Markets react emotionally in the short term.

But structural growth does not disappear overnight because of geopolitical escalation.

The question is not:

“Is today volatile?”

The question is:

“Has the long-term earning power materially changed?”

Concentration Risk Is Plateauing

Revenue growth can continue even while index weight stabilises.

Narratives cool.
Multiples compress.
Expectations normalise.

That does not equal collapse.

It equals repricing.

And repricing improves entry points.

Seasonality & Probability

Short-term volatility is common.

Permanent impairment in high-quality cash-flow-generating businesses is rare.

The distinction matters.

Where This Becomes Actionable

Over the weekend, I ran the March capital allocation framework across 20 elite compounders.

Several now show materially higher 12-month expected returns than they did just weeks ago - not because fundamentals improved, but because valuations compressed.

In multiple cases, fair value gaps now sit in the 30–60% range.

That does not mean immediate upside.

It means the math has shifted.

🔒 Want The Full Ranked Allocation Framework?

Paid members received the March allocation sheet yesterday - including 12-month expected return, bear case modelling, composite allocation ranking, and conviction tiers.

If you want structured exposure instead of reacting to headlines, upgrade below.

The Psychological Edge

When markets are euphoric, buying feels easy - but expected returns are lower.

When markets are uncomfortable, buying feels difficult - but expected returns often improve.

Today feels uncomfortable.

Futures are red.
Oil is volatile.
Headlines are escalating.

But valuation compression in quality businesses rarely persists indefinitely.

Multiples stabilise.
Cash flow compounds.
Sentiment eventually follows price.

Final Thought

The market doesn’t announce when odds improve.

It improves them quietly - during repricing.

Volatility is noise.

Valuation compression is signal.

The difference between reacting emotionally and allocating rationally is structure.

That’s what this month’s ranked allocation framework is built to capture - before sentiment catches up.

- Dividend Talks

The market doesn’t announce when it improves your odds.

It doesn’t ring a bell.
It doesn’t send a notification.
It doesn’t turn the heatmap green first.

It simply compresses valuations… quietly.

And if fundamentals remain intact while multiples fall, expected returns rise.

That is what is happening right now.

This month, instead of screening for “high yield,” I focused on something more important:

Elite businesses trading below 12-month fair value.

Not meme stocks.
Not broken balance sheets.
Not turnaround speculation.

High-quality compounders with durable free cash flow, strong ROIC, and resilient earnings power.

And many are trading 20–60% below where I estimate fair value over the next 12 months.

What’s Changed In March

Last month’s list focused primarily on undervalued dividend stocks.

This month is different.

March’s spreadsheet ranks companies by:

• 12-Month Expected Return (fair value gap + yield)
• Bear Case Return (conservative valuation scenario)
• Allocation Rank (upside + ROIC + balance sheet strength)
• Conviction Tier
• Personal ownership disclosure

Instead of just asking:

“Is this cheap?”

We ask:

“What is the expected return over the next 12 months - and is the business high quality enough to justify it?”

That distinction matters.

What Stands Out This Month

1️⃣ Valuation Compression in Quality

Several elite compounders are trading well below their long-term valuation norms:

Microsoft
Mastercard
Accenture
Intuit
S&P Global
ADP
Novo Nordisk

These are not distressed businesses.

They are businesses the market is temporarily repricing.

That creates opportunity.

2️⃣ Healthcare Mispricing

Healthcare continues to show asymmetric setups.

Novo Nordisk
UnitedHealth
Abbott
Zoetis
Elevance

are trading below historical valuation bands despite strong free cash flow and durable demand.

3️⃣ Financials & Asset Managers Reset

Several financials and alternative asset managers have seen valuation compression despite long-term structural growth drivers.

The spreadsheet quantifies whether that compression translates into compelling 12-month return potential - not just a low P/E ratio.

How This Spreadsheet Is Designed To Be Used

The March file includes:

• A ranked Capital Allocation table
• 12-Month Expected Return
• 12-Month Bear Case Return
• Allocation ranking combining upside, ROIC, and leverage
• Conviction tiers
• Personal ownership disclosure

You can approach it three ways:

Income Focus → Dividend Yield
Value Focus → % From Expected Price
Quality Focus → ROIC + Net Debt

This is a capital allocation framework.

Not a shopping list.

Risk Context

Not every name is recession-proof.

Some have experienced significant drawdowns during past downturns.

That’s why I include:

• Bear case return assumptions
• Balance sheet metrics
• Quality filters

Opportunity exists when valuations compress - not when risk disappears.

Why This Matters Now

When markets are euphoric, expected returns fall.

When markets compress quality, expected returns rise.

The best setups rarely look exciting in the moment.

They look boring.
They look uncertain.
They look temporarily out of favour.

But the math improves quietly before sentiment does.

That’s what this spreadsheet is designed to capture.

What Paid Members Get

Premium members receive:

• Two fully updated stock spreadsheets per month
• Ranked capital allocation tables
• 12-month expected return modelling
• Ongoing valuation updates
• Exclusive breakdowns and thesis updates

At £200/year, this is designed for investors who want structure, discipline, and a repeatable framework.

Not noise.

March Spreadsheet

March Undervalued Compounders – Dividend Talks
Download available below for paid members.

Read more

The market doesn’t reward bravery.

It rewards discipline.

Over the past few months, several high-quality large caps have quietly drifted toward 52-week lows. When that happens, most investors assume opportunity.

But price alone isn’t opportunity.

Sometimes a 52-week low is a gift.

Sometimes it’s a warning.

This week, I ran five widely followed large-cap names through my discounted cash flow framework.

Three cleared my 20%+ margin of safety requirement.

Two failed - despite looking “cheap” on the surface.

Here’s what the numbers actually say.

Why 52-Week Lows Can Be Dangerous

A stock hitting a 52-week low tells you one thing:

Sentiment is weak.

It tells you nothing about intrinsic value.

To qualify as a buy in my framework, a stock must:

• Trade at least 20% below conservative intrinsic value
• Show forward P/E compression vs its 5-year average
• Have implied growth expectations below historical compounding
• Show no structural business deterioration

This week, three names passed.

Let’s start with the first.

1️⃣ Visa (V)

Current Price: $320
Reverse DCF Implied Growth: 8.3%
5Y FCF CAGR: 10%
10Y FCF CAGR: 18%
Forward P/E: 24
5Y Avg Forward P/E: 27

The market is currently pricing Visa as if it will grow free cash flow at roughly 8% long term.

That’s below its 5-year history.

Well below its 10-year compounding rate.

Meanwhile, the forward multiple sits below its historical average - despite no structural damage to the business.

Intrinsic Value Sensitivity

10% growth → $361 (13% upside)
12% growth → $417 (30% upside)
14% growth → $480 (50% upside)

Under a conservative 12% base case, intrinsic value is ~$417.

That implies ~30% upside from current levels.

Visa cleared my 20% margin of safety threshold.

Model Status: BUY

🔒 Before continuing:

Starting March 1st, annual membership will increase from £120 to £200.

Over the coming months, I’ll be expanding the depth of each report - including:

• Full DCF models for every highlighted stock
• Reverse DCF expectation analysis
• Bear / base / bull scenario modeling
• Probability-weighted return frameworks
• More detailed downside sensitivity work

If you’re already a member, your rate remains locked in.

If you’ve been considering upgrading, you can secure the current £120/year pricing before March 1st.

The full breakdown continues below.

Read more

The market doesn’t ring a bell at the bottom.

It tests your conviction on the way down.

Over the past few weeks, volatility has picked up, headlines have turned negative, and high-quality stocks have quietly slipped into correction territory. Fear spreads faster than fundamentals - and in moments like this, most investors freeze.

But price is not risk.

Overpaying is risk.
Buying without a framework is risk.
Letting emotion drive allocation decisions is risk.

This week, the selloff triggered three buy signals in my valuation model - the same framework I use to determine fair value, downside ranges, and exact buy zones.

I’m not calling a market bottom.

I’m responding to numbers.

In each case, the market is now pricing in growth slowdowns or margin pressure that look materially more pessimistic than the underlying cash flow trends justify. When that gap widens enough, risk/reward flips.

That’s what just happened.

In this article, I’ll break down:

• Why the broader market is pulling back

• What assumptions are now embedded in prices

• The three stocks that just entered my buy zone

• And how I’m thinking about risk if the market falls another 10–20%

Free readers get the full thesis and one complete buy signal.

Paid members unlock the full valuation sheets - including exact buy levels, bear/base/bull scenarios, downside probabilities, and how I’m sizing positions in this environment.

Because during a selloff, the real question isn’t:

“Is this the bottom?”

It’s:

Has price finally become worth the risk?

Let’s start with what’s actually driving this pullback.

Market Update

U.S. equities finished the week lower as AI disruption concerns spread beyond technology and into a broader range of industries.

The S&P 500 fell 1.3%, with value outperforming growth for a seventh consecutive week. Leadership is rotating. Concentration risk is being reassessed.

What began as mega-cap weakness is now spilling into financials, insurers, real estate, and logistics names as investors speculate about second-order AI effects.

So far, those fears remain speculative - not reflected in revenues or structural deterioration - but they’ve increased volatility across risk assets. Crypto and precious metals weakened, while capital flowed into Treasuries and defensive sectors.

Labor Market: Still Firm

January’s jobs report came in stronger than expected, with 130,000 jobs added and unemployment ticking down to 4.3%.

The labor market isn’t breaking.

That pushed rate-cut expectations further out, with markets now pricing a higher probability that the Fed holds steady through mid-year.

Inflation cooled modestly, though core readings remain sticky enough to keep policy cautious.

Consumers Normalize

Retail sales stalled, and control group sales dipped slightly.

After a period where spending outpaced income growth, moderation isn’t surprising. It suggests normalization - not contraction.

The Bigger Picture

Fundamentals remain constructive.

Corporate earnings have been broadly solid, and the macro backdrop - steady growth, resilient profits, eventual policy easing - remains intact.

But markets are no longer pricing a straight-line expansion.

Volatility is rising. Rotations are accelerating. Valuation dispersion is widening.

And that environment rewards discipline.

Share

What Triggers a Buy Signal in My Model

I don’t buy simply because a stock is down.

Price weakness alone isn’t opportunity - it’s volatility.

A buy signal requires multiple conditions to align:

1️⃣ Defined Margin of Safety
The stock must trade meaningfully below my conservative fair value range - typically at least 20% under intrinsic value based on normalized cash flow assumptions.

2️⃣ Multiple Compression vs History
The forward P/E must sit below its 5-year average. When high-quality businesses trade at discounts to their own history during temporary uncertainty, sentiment often overshoots.

3️⃣ Mispriced Growth Expectations
The market must be embedding assumptions more pessimistic than long-term cash flow trends justify.

4️⃣ Risk-Adjusted Return Above Hurdle Rate
Modeled forward returns must compensate for macro and volatility risk.

5️⃣ No Structural Impairment
Temporary slowdowns are acceptable. Competitive moat erosion is not.

When those conditions line up, volatility becomes opportunity.

This week, three high-quality companies crossed that threshold.

Let’s start with the first.

1. Mastercard (MA)

The selloff hasn’t spared quality.

Even businesses with durable competitive advantages and consistent cash flow growth have seen their multiples compress. Mastercard is one of them.

Shares have pulled back as investors price in slowing consumer activity and moderating cross-border volumes.

But when you step back, the long-term thesis hasn’t changed.

Mastercard remains one of the most asset-light, high-return businesses in the market. Operating margins remain strong. Free cash flow conversion is consistent. The secular shift toward digital payments continues globally.

What’s changed isn’t the business.

It’s the valuation.

The forward P/E now trades below its 5-year average, reflecting a reset in expectations. Historically, periods of multiple compression during macro uncertainty - while cash flow continues compounding - have offered attractive forward returns.

Under normalized assumptions, shares now trade at a discount to intrinsic value that exceeds my required margin of safety.

Model Status: BUY Signal Triggered

Mastercard was the first signal - a high-quality compounder trading below its historical valuation range.

The next two buy signals are more asymmetric.

One is a mega-cap platform where operating leverage is improving while the market prices in deterioration.

The other is generating record free cash flow while sentiment remains anchored to prior growth scares.

Both show wider modeled upside than Mastercard - with higher volatility.

The full DCF breakdown - including growth assumptions, discount rates, and bear/base/bull valuation ranges - is available below for paid members.

Read more

Large-cap dividend stocks rarely show meaningful upside at the same time.

This month, several do.

After applying my 15%+ projected upside filter to dividend-paying companies above $10B, 52 names qualified.

That number alone isn’t unusual.

What stands out is how many are now trading near multi-year valuation compression - while dividend coverage and cash flow trends remain intact.

One of this month’s Top 5 currently shows up to 71% projected upside following a sharp reset in expectations.

Not because the business deteriorated.

Because sentiment compressed faster than fundamentals.

Pullbacks create noise.
Dislocations create opportunity.

Of the 52 qualifying names, roughly 10–15 meet my personal execution threshold based on valuation support, cash flow durability, and dividend strength.

Five stand out most clearly.

This report ranks the Top 5 and includes conviction scores, analyst alignment, 12-month upside projections, and the full 52-stock spreadsheet.

Let’s get into it.

Market Context

Pullbacks create volatility.
Discipline creates edge.

While headlines focus on macro uncertainty, analysts are revising models and adjusting price targets across sectors.

But analyst upside alone isn’t an advantage.

High price targets mean little if:

• The dividend isn’t durable

• Downside risk isn’t defined

• Valuation already reflects optimism

That’s where structured screening matters.

🔎 This Month’s Screening Framework

To qualify, each stock had to meet all of the following:

• Market cap above $10B

• Pays a reliable dividend

• Projected 12-month upside of 15%+

• Analyst consensus of Moderate Buy or Strong Buy

• Conviction Score of 8+

From the 52 qualifying names, I narrowed the list to roughly 10–15 that meet my execution threshold.

Five stand out most clearly.

They were ranked based on:

• Risk-adjusted upside

• Dividend durability

• Valuation gap vs historical multiples

• Defined downside support levels

All upside projections are cross-checked against historical valuation ranges to avoid target-driven optimism.

📊 February at a Glance

• Total qualifying stocks: 52

• Minimum projected upside: 15%

• Focus: Large-cap dividend payers

• Objective: Identify asymmetric setups - defined risk, material upside

Not all 15%+ projections are equal.

Some rely on optimism.
Others are supported by valuation compression and durable cash flow.

The five below reflect the latter.

🏆 This Month’s Top 5 High-Upside Dividend Stocks

#5 - Microsoft (MSFT)

Microsoft rarely screens as a high-upside dividend name.

This month, it does.

Shares have pulled back alongside broader technology names, compressing the forward multiple to levels below its 5-year average - despite continued free cash flow growth and durable operating margins.

That combination is rare for a company of this scale without underlying business deterioration.

What the Market Is Pricing In

At current levels, investors appear to be pricing in:

• Slower Azure growth normalization

• Elevated AI-related capital expenditure

• Margin stabilization rather than expansion

Those concerns are reasonable in the short term.

But they do not suggest structural impairment.

Microsoft remains one of the most asset-light, high-return platforms in the market, with diversified revenue across enterprise software, cloud infrastructure, and productivity ecosystems.

Valuation Context

The forward P/E now sits below its 5-year average, reflecting a meaningful reset in expectations.

Consensus still projects steady cash flow growth, and dividend coverage remains strong.

Under normalized assumptions, shares are trading within my valuation range for accumulation - levels typically seen during macro-driven pullbacks rather than company-specific weakness.

Dividend Durability

• Consistent dividend growth track record

• Conservative payout ratio

• Strong free cash flow conversion

Microsoft doesn’t offer the highest yield in the market.

It offers durability.

That’s why it earns a place in this month’s Top 5.

Microsoft ranks #5 this month.

The next four names show materially wider valuation gaps - including:

• A financial data moat trading near historical compression levels

• A global payments network priced below its long-term multiple range

• A semiconductor dividend grower with AI exposure

• And a large-cap enterprise platform showing up to 71% projected upside

Two of them are trading at multi-year valuation lows.

🔒 Paid members unlock:

• The remaining Top 4 ranked names

• Exact buy ranges

• Downside modeling

• Full 52-stock ranked spreadsheet

• Allocation priority framework

If you’re deploying real capital, entry levels matter as much as upside projections.

Read more

Most investors don’t lose money by picking bad companies - they lose it by overpaying for great ones.

I built a valuation system to answer one question every week:

👉 What’s actually worth buying *now* - and what only looks attractive?

Paid members get the same tools I use to size risk, find upside, and avoid value traps.

Each month, members receive:

• 📊 Undervalued Dividend Dashboard - A live spreadsheet ranking income stocks by valuation, yield safety, and margin of safety (released on the 1st).

• 🚀 High-Upside S&P 500 Valuations - Market leaders scored by upside, downside risk, and exact buy zones (released on the 15th).

• 🧠 Weekly Buy / Hold / Avoid analysis - Clear decisions - not just commentary - tied directly to articles like this one.

Free readers get the story.
Paid readers get the numbers, the risk, and the decision.

Over 140,000 investors follow my work across YouTube and Substack, using these models to manage real portfolios - not paper ideas.

Valuation never exists in a vacuum.

The answers a DCF gives you depend just as much on the broader market environment as they do on company-specific assumptions - growth rates, margins, discount rates, and risk appetite all move together.

That’s why before digging into the model outputs on the Magnificent 7, it’s worth stepping back and looking at what actually changed in markets last week.

Because the recent pullback in tech wasn’t random - it reflected shifting narratives around AI, capital spending, interest rates, and investor risk tolerance. And those shifts directly impact how much future cash flow the market is willing to pay for today.

With that context in mind, here’s the market setup going into the DCF analysis.

Market Update

It was a tale of two markets this week.

Big Tech - after months of carrying the market higher - finally stumbled. The Nasdaq had its worst week since November as investors started asking harder questions about AI: How much is too much spending? Are expectations simply too high? That doubt was enough to shake some of the market’s most crowded trades.

But while mega-cap growth stocks struggled, the rest of the market quietly strengthened.

Small caps, mid caps, value stocks - even the Dow - pushed higher. Money didn’t leave equities; it rotated. Investors moved out of expensive, AI-heavy names and into areas tied to the real economy - industrials, cyclicals, and other “old economy” sectors that had lagged for years.

The economic backdrop added to the tension. Labor data came in softer than expected. Private payroll growth slowed. Job openings fell to their lowest level since 2020. Layoff announcements spiked to levels not seen for a January since the financial crisis. The job market isn’t breaking - but it’s clearly cooling.

At the same time, manufacturing showed fresh signs of life. Activity expanded for the first time in a year, and new orders rebounded sharply. Services activity held steady in expansion territory. In short: parts of the economy are slowing, while others are quietly reaccelerating.

Bond markets leaned toward caution, with yields drifting lower as investors processed the softer labor data.

The bigger story isn’t a collapsing market - it’s a changing leadership cycle.

AI disruption fears and surging tech spending have sparked volatility, but the weakness has been concentrated in the mega-cap growth names that dominated returns for years. Meanwhile, improving industrial activity and broader economic resilience are supporting a rotation into under-owned sectors.

For portfolios, this shift matters. Rotation reduces concentration risk, opens the door to diversification, and helps normalize valuations after an extended period of tech-driven dominance.

The market isn’t falling apart. It’s rebalancing.

Last Weeks Winners & Losers

Top performers:

• Hershey (+19%)

• Bristol-Myers (+13%)

• Amgen (+12%)

• Merck & Co (+11%)

• UPS (+10%)

• Walmart (+10%)

Biggest drops:

• PayPal (-23%)

• Boston Scientific (-18%)

• S&P Global (-17%)

• ServiceNow (-14%)

• Oracle (-13%)

• Amazon (-12%)

  Share

  ---

  Notable News

Broadening the Cycle

The spotlight is shifting.

After years of tech dominating nearly every headline and portfolio, capital is moving back toward the so-called “old economy.” Energy. Industrials. Transportation. Consumer staples. Regional banks. The kinds of businesses tied to real assets and real activity - not just digital scale.

These sectors had been left behind during the AI-fueled surge in mega-cap growth. Now, they’re quietly outperforming.

Why the change?

First, valuations matter again. Many of these companies trade at far more reasonable levels than the crowded tech leaders. Second, earnings growth is accelerating outside of technology. And third, investors are looking to reduce concentration risk after years of heavy exposure to a handful of mega-cap names.

The macro backdrop is helping. Higher-income consumers continue to spend. Fiscal support from last year’s tax bill is beginning to flow through the system, boosting refunds and encouraging business investment. And AI-related capital spending - ironically - also benefits industrial suppliers, utilities, and infrastructure plays beyond just the tech platforms themselves.

Put together, the economy looks more balanced than it has in years. Growth doesn’t have to come from just one corner of the market.

Economists are taking note. Expectations for U.S. GDP have been revised higher, with growth now projected around 2.5% in 2026.

This isn’t the end of tech. It’s the broadening of the cycle.

Compression, Not Collapse

Tech isn’t slowing down - but investors are paying less for it.

Earnings across the sector are still growing at one of the fastest clips in the market, up roughly 30% year over year. The weakness we’ve seen hasn’t been about profits collapsing. It’s been about valuations resetting. Forward multiples have compressed sharply as investors rethink how much they’re willing to pay for future growth.

Two forces are driving that reset.

First: AI disruption fears.
The very technology that powered the rally is now raising uncomfortable questions. New AI tools are automating tasks across legal, marketing, finance, and other functions long dominated by established software firms. Investors are wondering whether parts of the software stack could be pressured - or even displaced - faster than incumbents can adapt.

Software Stocks drawdown from 52 week high:

So far, the selling has been broad and largely indiscriminate. In some cases, valuations may already reflect a heavy dose of disruption risk relative to current fundamentals. Industry leaders argue AI will build on existing platforms rather than replace them outright. But the reality is clear: some companies will emerge stronger, others weaker - and it’s still too early to know which is which. That uncertainty is fueling volatility.

Second: the AI spending race.
At the same time, mega-cap tech companies are ramping up capital expenditures at an extraordinary pace. Data centers, chips, infrastructure - the buildout is massive. What used to be capital-light businesses are now investing at industrial scale.

That spending supports parts of the market, especially semiconductors and infrastructure plays. It also feeds into broader economic growth. But it comes with risk. Investors are beginning to ask whether the returns on this AI arms race will justify the scale and speed of investment - particularly as some firms lean more on debt to fund expansion.

In short, this isn’t an earnings problem. It’s a confidence and valuation adjustment.

The AI story isn’t over. But the market is no longer willing to price it as a straight line higher.

When Speculation Cools

Speculation is losing steam.

Some of the market’s most momentum-driven trades have rolled over in recent months. Bitcoin has fallen sharply from its highs, and precious metals - after a powerful run - have also pulled back. While gold and silver remain above year-ago levels, the easy upside appears to have stalled.

This shift adds to the broader risk-off tone we’re seeing across markets. Part of the cooling may reflect the Fed’s recent messaging: rate cuts are unlikely to arrive quickly. When liquidity expectations reset, speculative assets often feel it first.

When speculation cools, discipline matters more than ever.

Share

Earnings Week

Join 120,000+ investors on YouTube! 🎥
We break down earnings, market moves, and exclusive insights you won’t find anywhere else.

Don’t miss out - hit the button below to watch and subscribe now! 👇

YouTube Channel 🔔
Subscribe today and stay ahead of the market!

Fear & Greed Index

🔒 This section contains full valuation models, buy zones, and downside scenarios for all Mag7 stocks. Paid members unlock the complete research below.

The Question That Matters

All of this - the rotation, the multiple compression, the AI spending surge, the cooling risk appetite - feeds into one thing:

What are the Magnificent 7 actually worth today?

If leadership is broadening…
If multiples are compressing…
If capital intensity is rising…

Then fair value changes.

So I ran updated discounted cash flow models on each of the Magnificent 7 - using revised growth assumptions, margin scenarios, and a higher-for-longer rate backdrop.

Here’s what the numbers say.

1. Microsoft (MSFT)

Valuation

The forward P/E sits below the historical - 22.8x v 31.5x. This could indicate the company is potentially severely undervalued. It is also one of the lowest valuations they have traded for in at least the last 5Y.

The blue tunnel highlights that Microsoft is now outside of the fair value boundary indicating potential undervaluation.

Looking at the last 10Y we note that Microsoft rarely trades at a massive discount.

DCF Model

Using our DCF model a few things to note:

• 10.40% is baked into the FCF growth moving forwards.

• 5Y FCF CAGR sits at 8%

• 10Y CAGR sits at 13%

• Using 12% (the lower rate) gives an intrinsic value of $444.

• Using 14% (the middle rate) gives an intrinsic value of $502.

• Using 16% (the higher rate) gives an intrinsic value of $568.

Using the middle growth rate of 14%, we get an intrinsic value of $502 which leads to a 20% margin of safety.

On average wall street see 50% upside by the end of 2026.

What the market is pricing in

The current valuation implies that growth in Azure and enterprise software decelerates meaningfully from recent peaks, despite continued margin expansion and strong free cash flow conversion.

The market appears to be pricing Microsoft as a mature platform rather than a structural AI beneficiary.

If AI-driven productivity gains sustain even mid-teens cash flow growth, today’s multiple leaves room for upside without requiring heroic assumptions.

Verdict: BUY

🔒 The rest of this analysis includes full DCF models, upside/downside scenarios, and exact buy zones for the remaining Magnificent 7.

Read more

Most investors don’t lose money by picking bad companies - they lose it by overpaying for great ones.

I built a valuation system to answer one question every week:

👉 What’s actually worth buying *now* - and what only looks attractive?

Paid members get the same tools I use to size risk, find upside, and avoid value traps.

Each month, members receive:

• 📊 Undervalued Dividend Dashboard - A live spreadsheet ranking income stocks by valuation, yield safety, and margin of safety (released on the 1st).

• 🚀 High-Upside S&P 500 Valuations - Market leaders scored by upside, downside risk, and exact buy zones (released on the 15th).

• 🧠 Weekly Buy / Hold / Avoid analysis - Clear decisions - not just commentary - tied directly to articles like this one.

Free readers get the story.
Paid readers get the numbers, the risk, and the decision.

Over 130,000 investors follow my work across YouTube and Substack, using these models to manage real portfolios - not paper ideas.

This market is starting to punish expectations instead of bad businesses.

We’re seeing a pattern: strong companies beat earnings - and still sell off. Not because the business is broken, but because valuation, spending, and guidance collide with investor psychology.

That’s where opportunity lives.

In today’s report, I’m breaking down three post-earnings selloffs where the market reaction looks disconnected from long-term fundamentals - and where valuation is quietly resetting risk and reward.

But first, here’s what changed in the market this week.

Market Update

The market flirted with a milestone this week - and then thought better of it.

The S&P 500 briefly pushed past the 7,000 mark, setting a new intraday high before momentum faded and prices slipped back. The move felt symbolic: optimism was there, but conviction wasn’t. Beneath the surface, leadership narrowed. Large-cap value stocks quietly outperformed their growth peers, while small- and mid-cap names struggled to keep up, ending the week in the red. Within the S&P 500, communication services and energy did the heavy lifting, while health care stocks were the biggest drag.

Away from equities, the economic backdrop grew more complicated.

Consumer confidence took a sharp turn lower in January. The Conference Board’s index fell to 84.5, down from 94.2 in December and its lowest reading since May 2014. The drop was steeper than expected and reflected growing unease about both the economy and the labor market. Households, it seems, are feeling less secure - even as headline economic data remains relatively firm.

The labor market itself sent mixed signals. Initial jobless claims edged down slightly to 209,000 for the week ended January 24, still hovering near historically low levels. Continuing claims fell to roughly 1.83 million, the lowest since September 2024, suggesting that workers who lose jobs are still finding new ones relatively quickly.

On the manufacturing front, delayed data finally offered a positive surprise. Durable goods orders rebounded sharply in November, rising 5.3% after a decline in October. Core capital goods orders - a key proxy for business investment - also moved higher, climbing 0.7%.

At the same time, inflation pressures at the producer level showed signs of re-accelerating. Producer prices rose 0.5% in December, well above expectations, driven largely by higher service prices and widening margins for wholesalers and retailers.

That inflation backdrop helped frame the Federal Reserve’s latest decision. After three consecutive rate cuts, the Fed hit pause, holding its benchmark rate steady in the 3.50%–3.75% range. While two policymakers dissented in favor of another cut, the majority pointed to an economy that continues to expand at a “solid pace.” Chair Jerome Powell emphasized that rates no longer appear “significantly restrictive” and reinforced that future moves will be decided meeting by meeting.

Adding another layer of uncertainty, President Trump announced the nomination of former Fed Governor Kevin Warsh to succeed Powell when his term ends in May, pending Senate confirmation - raising fresh questions about the future direction of U.S. monetary policy.

For now, markets are left balancing optimism about growth with lingering concerns about inflation, policy, and the consumer. The S&P 500 may have touched 7,000 - but whether it’s ready to stay there remains an open question.

Subscribe now

Last Weeks Winners & Losers

Top performers:

• Verizon (+13%)

• Royal Caribbean (+13%)

• Texas Instruments (+12%)

• AT& T (+11%)

• Meta (+9%)

Biggest drops:

• Axon Enterprise (-21%)

• UnitedHealth (-19%)

• Palantir (-14%)

• ServiceNow (-12%)

• Intuit (-12%)

Share

Notable News

Earnings Season

Earnings season is no longer warming up - it’s running at full speed.

The fourth-quarter reporting cycle hit a major inflection point this week as several members of the “Magnificent 7” took center stage. Apple, Meta, Microsoft, and Tesla all delivered results that topped expectations. But beating estimates wasn’t enough to guarantee a rally. Market reactions were uneven, with Microsoft shares sliding sharply as investors fixated on heavy capital spending plans and signs of slower growth in its cloud business.

Zooming out, the bigger picture remains constructive. S&P 500 earnings are on track to grow roughly 10.1% year over year in the fourth quarter, a meaningful acceleration from earlier in the year. Technology continues to lead the charge, with profits expected to climb more than 25%, but strength isn’t confined to just one corner of the market. Eight of the index’s eleven sectors are forecast to report higher earnings, pointing to a healthier and more durable expansion.

That breadth matters. Broad-based earnings growth tends to support a widening of market leadership - something investors have been waiting for after months of concentration in a handful of mega-cap names. And the outlook doesn’t stop with this quarter. Profit growth is expected to continue building momentum, with estimates calling for acceleration into 2027.

In short, while stock-by-stock reactions may remain choppy, the earnings engine driving this market looks increasingly hard to ignore.

Inflation

The Federal Reserve stepped to the sidelines this week.

After three straight rate cuts late last year, the Federal Open Market Committee held the federal funds rate steady at 3.5%–3.75% following its January meeting. The decision itself was widely expected, but the tone of the accompanying statement mattered just as much. Policymakers upgraded their view of the economy, noting that activity continues to expand at a solid pace, supported by resilient consumer spending and improving business investment.

The Fed also struck a more constructive note on the labor market. While job growth remains subdued, officials acknowledged signs of stabilization - an important shift after months of concern about cooling employment conditions. Inflation, however, remains the central challenge. The committee reiterated that price pressures are still elevated, even if they are no longer accelerating at the pace seen earlier in the cycle.

Taken together, the language suggests a central bank growing more comfortable with patience. After moving quickly to ease policy in recent months, the Fed now appears willing to wait, letting the data guide its next steps rather than rushing toward further cuts.

Inflation data helps explain that caution. The Fed’s preferred measure, the Personal Consumption Expenditures (PCE) price index, has continued to cool, helped by easing services inflation. That progress, however, has been partially offset by a renewed pickup in goods prices, driven in part by tariffs. The result is an inflation picture that is improving - but slowly. Price growth remains above the Fed’s 2% target, and the pace of disinflation has clearly decelerated.

For now, the message from policymakers is clear: policy is on hold, confidence in the economy is improving, and the bar for additional rate cuts has quietly moved higher.

Upcoming Rate Cuts

The leadership headlines out of Washington haven’t changed the bigger picture for monetary policy.

The difference now is speed. After moving quickly late last year, the Fed appears set to slow the pace of easing, opting for a more deliberate approach.

At current levels, policy is already hovering close to neutral. With the fed funds rate sitting at 3.5%–3.75% and PCE inflation running around 2.8% on an annualized basis, the math supports that view. A neutral policy rate in the U.S. is typically estimated at roughly 0.75% to 1% above inflation - placing today’s stance squarely in that zone.

That positioning gives the Fed flexibility. If inflation continues to grind lower, policymakers should have room to resume cutting rates without meaningfully reaccelerating price pressures. The hurdle isn’t direction, but confidence. For now, the Fed looks less concerned about being too tight - and more focused on making sure it doesn’t move too fast.

Share

Earnings Week

Join 120,000+ investors on YouTube! 🎥
We break down earnings, market moves, and exclusive insights you won’t find anywhere else.

Don’t miss out - hit the button below to watch and subscribe now! 👇

YouTube Channel 🔔
Subscribe today and stay ahead of the market!

Fear & Greed Index

🔒 This section contains full valuation models, buy zones, and downside scenarios for all three stocks. Paid members unlock the complete research below.

3 Stocks to Buy After Earnings Crash

Earnings season often creates some of the best opportunities for long-term investors - not because the businesses suddenly became worse, but because short-term expectations collided with reality.

In many cases, post-earnings selloffs are driven more by guidance tweaks, sentiment shifts, or positioning than by true deterioration in long-term fundamentals.

Below are three stocks that sold off after earnings, where I believe the market reaction has created an attractive risk/reward setup for patient investors.

Two of these names are among the most widely held and closely watched stocks in the market.

They’re businesses most investors assume they can only buy on strength - not after sharp post-earnings pullbacks.

That’s what makes this setup so interesting: the market is briefly offering access to quality that rarely goes on sale.

1. Microsoft (MSFT)

Why Microsoft Crashed After Earnings

On the surface, Microsoft’s Q2 FY26 earnings looked strong. The company beat expectations on both revenue and earnings, reported 17% year-over-year revenue growth, and delivered another quarter of robust cloud performance.

But the stock didn’t sell off because of weak results. It sold off because investors are increasingly focused on what Microsoft is spending to fuel AI growth - not just what it’s earning.

The headline concern was a massive surge in capital expenditures. Microsoft reported approximately $37.5 billion in quarterly capex, up roughly 66% year-over-year, driven by AI data centers, GPUs, and infrastructure build-out. That figure stunned the market and raised fresh questions about the near-term return on these investments.

At the same time, Azure cloud growth - while still strong - came in at around 38% year-over-year, slightly below what the most bullish investors were hoping for and down modestly from prior quarters. In a stock priced for continued acceleration, even a small deceleration can trigger an outsized reaction.

Investors are also becoming more sensitive to free cash flow and margins. AI workloads are significantly more capital- and energy-intensive than traditional cloud services. Microsoft Cloud gross margins declined to around 67%, reflecting higher infrastructure and operating costs tied to AI expansion.

Another underappreciated factor: concentration risk. Roughly 45% of Microsoft’s $625 billion cloud backlog is tied to OpenAI, which has become a major driver of both demand and spending.

While that highlights enormous future opportunity, it also increases investor scrutiny around timing, monetization, and capital efficiency.

In short, this wasn’t a verdict on Microsoft’s business quality. It was a reassessment of the timeline and economics of AI returns. The market is asking a harder question: how quickly will today’s massive infrastructure spending translate into incremental profits - even for a best-in-class operator like Microsoft?

That shift in focus - from growth to return on growth - is what drove the sharp post-earnings selloff.

A Business of Exceptional Quality

It’s easy to get caught up in short-term earnings reactions. But zooming out, Microsoft’s long-term fundamentals tell a very different story - one of consistent execution, widening moats, and elite capital efficiency.

Over the past decade, Microsoft has quietly transformed into one of the highest-quality cash-generating businesses in the global market.

Free cash flow per share has grown from $3.15 in 2016 to $9.63 in 2025 - more than a 3x increase. That kind of growth reflects not just revenue expansion, but disciplined cost control, operating leverage, and durable pricing power.

Revenue growth has also been remarkably consistent. In 7 of the last 10 years, Microsoft has delivered double-digit sales growth, an extraordinary feat for a company of this size and scale. Few mega-caps have compounded at this rate while also expanding profitability.

Returns on capital remain elite. Microsoft’s ROIC sits around 22% (TTM), placing it firmly among the highest-quality large-cap businesses in the market. This signals that incremental investment is still generating strong economic value - even as the company operates at massive scale.

Profitability has structurally improved as well. Over the same period:

• Operating margins have expanded from ~30% to ~47%

• Free cash flow margins now sit around 25% (TTM)

This margin expansion reflects the shift toward higher-margin cloud, software, and subscription-based revenue - and highlights Microsoft’s growing operating leverage.

Balance sheet strength adds another layer of resilience. Net debt to EBITDA of just 0.18x gives Microsoft enormous financial flexibility, allowing it to invest aggressively in growth while maintaining one of the strongest balance sheets in large-cap tech.

Finally, cloud has been a powerful long-term growth engine. Microsoft’s cloud revenue has grown at a 27% CAGR from 2019 to 2025, transforming the business mix and anchoring long-duration growth in recurring, mission-critical workloads.

Taken together, these metrics paint a clear picture: this is not a fragile, hype-driven growth story. Microsoft is a structurally stronger, more profitable, and more cash-generative business than it was a decade ago - even before layering in the full potential of AI.

🔒 Paid Members: Microsoft’s full valuation model, buy zones, downside risk, and my verdict (Buy / Hold / Avoid) are unlocked below - along with deep dives on Stock 2 and 3.

Free readers get the story.
Paid readers get the numbers and the decision.

Read more

Each month, premium subscribers get a fully updated dividend stock spreadsheet - highlighting only the stocks that pass a strict undervaluation and income screen.

This February, 46 dividend stocks made the cut. Each one is undervalued, cash-flow-generating, and positioned for long-term upside as the market re-evaluates quality.

If your goal is to build reliable income while buying strong businesses at a discount, this is exactly where I’m looking. The complete list and full breakdown are available exclusively to paid members.

Subscribe to unlock:

• Two exclusive monthly stock spreadsheets

• Undervalued dividend stocks and high-upside S&P 500 opportunities

• Available only to paid members

How We Identify Undervalued Stocks (Quick Recap)

Every stock in this month’s list is selected using a disciplined, repeatable framework designed to identify dividend-paying companies trading below fair value - without sacrificing balance sheet strength or payout sustainability.

In practice, that means:

• Elevated dividend yields vs. historical averages (Dividend Yield Theory)

• Discounted valuations, typically forward P/E below long-term norms

• High dividend safety, generally scores of 60+

• 15%+ targeted medium-term upside

• Conservative balance sheets (Net Debt/EBITDA < 3x; < 5x for REITs)

This approach helps us focus on high-quality income stocks that are mispriced today but positioned to deliver reliable income and long-term capital appreciation.

How to Use This Spreadsheet

The spreadsheet below contains 46 dividend-paying stocks that passed this month’s valuation, income, and quality screen. Every name is trading below estimated fair value while maintaining acceptable dividend safety and balance sheet strength.

You can sort the spreadsheet depending on your objective:

• Income-focused: Dividend Yield, Dividend Safety

• Value-focused: P/E vs 5-Year Average P/E, % From Expected Price

• Quality-focused: ROIC, Free Cash Flow history, Net Debt/EBITDA

All figures reflect the most recent available data and are updated monthly.

Below are the February stocks that passed every filter above.

Read more